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Introduction
Glucose is an essential nutrient that sustains cell growth and 
energy production in most living cells. Glucose uptake occurs 
by facilitated diffusion through a family of plasma membrane–
localized transporters and is a highly regulated process. For ex-
ample, insulin stimulates glucose storage in adipocytes through 
the increased targeting of the glucose transporter Glut4 to the 
plasma membrane (Cushman and Wardzala, 1980; Karnieli 
et al., 1981; Martin et al., 2000). Glut4 endocytosis is further 
repressed by insulin in adipocytes (Jhun et al., 1992; Czech 
and Buxton, 1993) or by membrane depolarization in muscle 
cells (Wijesekara et al., 2006). Recent work indicates that en-
ergetic stress stabilizes another glucose transporter, Glut1, at 
the cell surface (Wu et al., 2013). Importantly, alterations in 
Glut transporter availability at the plasma membrane are as-
sociated with several human disorders. The insulin-dependent 
increase of plasma membrane–associated Glut4 is defective 
in type 2 diabetic patients (Zierath et al., 1996; Ryder et al., 
2000). Moreover, Glut transporters, especially Glut1, are over-
expressed in cancer cells, likely contributing to the increase in 
biomass production and tumor progression (Yun et al., 2009; 
Calvo et al., 2010). Thus, understanding the mechanisms regu-
lating glucose transporter availability at the plasma membrane 
is of prime importance.
The yeast Saccharomyces cerevisiae is an excellent model 
to investigate cellular adaptation to nutritional signals. In con-
trast to mammalian cells that are exposed to a relatively constant 
supply of nutrients, this unicellular organism evolved adaptive 
mechanisms to cope with highly variable nutrient availability in 
the environment (Smets et al., 2010). In particular, its genome 
encodes 20 hexose transporters that display various affinities 
toward their substrates, transport kinetics, and specific regula-
tions. This warrants an efficient use of glucose over the broad 
range of concentrations they can encounter in the wild (Krucke-
berg, 1996; Reifenberger et al., 1997). A well-known regulation 
of hexose transporters occurs at the transcriptional level, with 
multiple expression patterns favoring cell adaptability to varia-
tions in sugar availability.
Additionally, glucose also controls the abundance of 
carbon source transporters by regulating their endocytosis. 
Glucose induces the endocytosis of alternative carbon source 
transporters to ensure that glucose is used in priority when 
available (Medintz et al., 1996; Horak and Wolf, 1997; Lucero 
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and Lagunas, 1997; Paiva et al., 2002; Ferreira et al., 2005). 
Glucose also triggers the endocytosis of the high-affinity glu-
cose transporters Hxt2 and Hxt6, which are no longer required 
when glucose is present at high concentrations (Kruckeberg et 
al., 1999; Nikko and Pelham, 2009). Thus, by selectively re-
modeling the landscape of transporters present at the plasma 
membrane, endocytosis allows the efficient use of nutrients and 
is thus a core component of cell adaptation.
The selective endocytosis of transporters requires their 
prior ubiquitylation by the Nedd4-like E3 ubiquitin ligase Rsp5 
(Hein et al., 1995; MacGurn et al., 2012). This posttranslational 
modification acts as a molecular signal that drives transporter 
internalization and progression in the endocytic pathway. Ac-
cordingly, glucose promotes the ubiquitylation of several al-
ternative carbon source transporters, such as Gal2 (galactose), 
Mal61 (maltose), and Jen1 (lactate; Medintz et al., 1998; Horak 
and Wolf, 2001; Paiva et al., 2009).
Rsp5 uses adaptor proteins that contribute to the speci-
ficity and the timing of transporter ubiquitylation with respect 
to the physiology of the cell. Particularly, a family of arrestin- 
related trafficking adaptors (ARTs), related to visual/β-arrestins 
of metazoans, is crucial for stress- or nutrient-regulated endocy-
tosis of transporters (Lin et al., 2008; Nikko et al., 2008; Becuwe 
et al., 2012a; Piper et al., 2014). The function of arrestin-related 
proteins is regulated by nutrient signaling pathways, allowing 
control of transporter endocytosis by nutritional challenges 
(O’Donnell et al., 2010, 2015,; MacGurn et al., 2011; Merhi 
and André, 2012). For instance, the glucose-induced endocy-
tosis of Hxt6 requires the ART Rod1/Art4 (Nikko and Pelham, 
2009), whose function is regulated by the yeast 5′ AMP-acti-
vated kinase (AMPK) orthologue Snf1 (Becuwe et al., 2012b; 
O’Donnell et al., 2015; Llopis-Torregrosa et al., 2016).
Here, we examine the mechanism governing endocyto-
sis upon glucose deprivation. We show that in this condition, 
several high-affinity glucose transporters are induced, but un-
expectedly, they are subsequently endocytosed and degraded 
after a few hours, possibly because of the lack of substrate to 
transport. Their endocytosis depends on a single ART protein, 
Csr2/Art8, which is regulated by glucose availability at multiple 
levels. Csr2 is the first yeast ART regulated at the transcrip-
tional level, a process that involves the yeast AMPK Snf1. This 
transcriptional regulation renders Csr2 expression restricted to 
glucose-depleted conditions. Csr2 is further regulated at the 
posttranslational level: glucose replenishment switches Csr2 
from an active, ubiquitylated form to an inactive, deubiquityl-
ated, and phosphorylated form that associates with 14-3-3 pro-
teins, in a process that involves protein kinase A (PKA). These 
data establish novel regulatory mechanisms by which ART pro-
teins control endocytosis.
Results
Glucose depletion signals endocytosis of 
the high-affinity hexose transporters 
Hxt6 and Hxt7
We investigated the molecular events responsible for trans-
porter endocytosis in glucose-deprived cells. Hxt6 is a high-af-
finity hexose transporter that is barely detectable in cells grown 
in glucose medium and becomes expressed upon switching 
cells to very low glucose or glucose-free medium (Ozcan and 
Johnston, 1995, 1996; Liang and Gaber, 1996; Ye et al., 2001). 
Accordingly, upon transfer to lactate-containing medium (a 
nonfermentable carbon source that supports growth by oxi-
dative phosphorylation), Hxt6 was expressed and targeted to 
the plasma membrane (Fig.  1  A), but it subsequently exhib-
ited a complete vacuolar localization after 24 h. Hxt7, another 
high-affinity hexose transporter that is nearly identical to Hxt6 
and displays a comparable transcriptional regulation, behaved 
similarly (Fig.  1  A). Hxt6 was also endocytosed when cells 
were switched to a medium containing ethanol (another nonfer-
mentable carbon source) or no carbon source (Fig. 1 B). Thus, 
Hxt6 endocytosis did not correlate with growth arrest and was 
likely triggered by glucose removal rather than by the presence 
of lactate. Western blots on total cell lysates confirmed a de-
crease in Hxt6-GFP abundance over time and the coincident ap-
pearance of a GFP-containing degradation product, originating 
from the partial vacuolar degradation of Hxt6-GFP (Fig. 1 C). 
Consistent with regulation by endocytosis, Hxt6-GFP degra-
dation was strongly affected in the endocytic mutant vrp1Δ 
(end5Δ; Munn et al., 1995) or in the rsp5 hypomorphic mutant 
npi1 (Hein et al., 1995; Fig. 1 C). Therefore, Hxt6 is transiently 
expressed at the plasma membrane upon glucose depletion and 
is subsequently endocytosed and degraded in a ubiquitin- and 
Rsp5-dependent manner.
The ART protein Csr2 is required for Hxt6 
endocytosis in glucose-depleted medium
ART family adaptor proteins assist Rsp5 in its functions in en-
docytosis (Nikko et al., 2008; Nikko and Pelham, 2009; Ha-
takeyama et al., 2010; O’Donnell et al., 2010, 2015; MacGurn et 
al., 2011; Becuwe et al., 2012b; Merhi and André, 2012; Kara-
chaliou et al., 2013; Alvaro et al., 2014). Accordingly, in a strain 
lacking nine ART genes (Nikko and Pelham, 2009), Hxt6 was no 
longer endocytosed upon transfer to lactate medium (Fig. 1 D).
The expression of a single ART protein, Csr2/Art8, but 
not its close paralogue Ecm21/Art2, restored Hxt6 endocytosis 
in the 9-arrestin mutant (Fig. 1 D). The deletion of CSR2 altered 
transporter trafficking and degradation in these conditions, but 
not that of ECM21 (Fig. S1, A and B), showing that Csr2 is 
required for Hxt6 endocytosis. However, in the csr2Δ mutant, 
Hxt6-GFP was expressed to a much lower level compared with 
the wild-type (WT) strain, which may interfere with our con-
clusions (Fig. S1, A and B). Of note, only the expression of 
Hxt6 and Hxt7 appeared affected, not that of other transport-
ers (Fig. S1 C; see also Fig.  4). The Hxt6 expression defect 
observed in a csr2Δ strain was not due to a nonconventional 
role of Csr2 in transporter expression, because it could not be 
suppressed by various Csr2-encoding plasmids (Fig. S1, D–F). 
To circumvent this problem, we generated and characterized 
another CSR2 mutant allele, which we named csr2-1, in which 
Hxt6 expression was comparable with that in WT cells (Fig. S1, 
G–I). Reassessing the localization and stability of Hxt6-GFP 
in the csr2-1 strain upon transfer to lactate medium confirmed 
the requirement of Csr2 for Hxt6-GFP endocytosis and degra-
dation (Fig. 1, E, F, and I), although we cannot formally rule 
out a minor contribution of other ARTs. Similar results were 
obtained with Hxt7, which was also endocytosed and degraded 
in a Csr2-dependent fashion (Fig. 1, G–I).
Csr2 regulates Hxt6 homeostasis in the 
context of a yeast colony
Previous work established that yeast colonies constitute a com-
plex, stratified system composed of layers of yeast cells in distinct 
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physiological and metabolic states (Váchová et al., 2009; Čáp et 
al., 2012). Whereas upper cells are glycolytic with a low respi-
ratory metabolism, lower cells behave oppositely (Palková et 
al., 2014; Čáp et al., 2015). Lower cells can be further stratified 
into “upper” and “lower” lower cells (Podholová et al., 2016). 
The existence of metabolic gradients across a colony suggested 
that transporter endocytosis might occur at the frontier of differ-
ent subpopulations. Yeast expressing Hxt6-GFP was grown on 
respiratory medium, and cross sections of 4-d-old differentiated 
colonies were observed using two-photon excitation confocal 
Figure 1. Csr2 regulates the endocytosis of the high-affinity hexose transporters Hxt6 and Hxt7 upon a switch to a glucose-deprived medium. (A) Localiza-
tion of endogenously GFP-tagged Hxt6 and Hxt7 in cells grown overnight in glucose (Glc medium (exponential phase) and switched to lactate-containing 
medium for the indicated times. PM, plasma membrane; V, vacuole. (B) Localization of Hxt6-GFP in WT cells grown on glucose medium and switched to 
the indicated media. (C) WT, vrp1Δ, and npi1 cells expressing Hxt6-GFP were grown in the indicated conditions. Total cell lysates were immunoblotted 
with anti-GFP and anti-PGK (phosphoglycerate kinase; used as a loading control) antibodies. Free GFP: originates from the vacuolar degradation of full-
length Hxt6-GFP. (D) Localization of Hxt6-GFP in WT, 9-arrestinΔ and 9-arrestinΔ mutant cells complemented with a plasmid encoding either Ecm21/Art2 
or Csr2/Art8. (E) Localization of Hxt6-GFP in WT and csr2-1 mutant cells in the indicated growth conditions. (F) From the experiment presented in E, total 
cell lysates were prepared and immunoblotted. (G) Localization of Hxt7-GFP in WT and csr2-1 mutant cells in the indicated growth conditions. (H) From 
the experiment presented in G, total cell lysates were prepared and immunoblotted. (I) Western blot signals were quantified using ImageJ (n ≥ 3 inde-
pendent experiments); the ratio of the free GFP signal over the total GFP signal (7 h lactate time point) is represented (±SEM) for Hxt6-GFP (orange) and 
Hxt7-GFP (purple). **, P < 0.01.
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microscopy (Váchová et al., 2009). The results show that Hxt6 
was expressed mostly in lower cells (Fig. 2 A), where it local-
ized to the plasma membrane (Fig. 2, C and D). This is consis-
tent with the fact that these cells rely on respiratory metabolism 
for survival. In upper cells, which are respirofermenting cells 
(Čáp et al., 2015), the global Hxt6-GFP fluorescence decreased, 
and the fluorescent signal localized mostly to the vacuole. Per-
forming the same experiment on a csr2-1 background revealed 
an increase in global Hxt6-GFP fluorescence of the colony, as 
well as increased Hxt6-GFP plasma membrane localization in 
upper cells and in cells at the margins of the colony (Fig. 2, B 
and D). Furthermore, Hxt6-GFP was also much more expressed 
in yeast cells proximal to the agar medium in the csr2-1 mutant 
(lower layers of lower cells; Fig. 2, C and D). These results lend 
support to a key role of Csr2 in Hxt6 homeostasis in the physi-
ological context of a yeast colony.
Csr2 interacts with Hxt6 in vivo and 
promotes its ubiquitylation
Using bimolecular fluorescence complementation (BiFC; 
Hu et al., 2002), we obtained evidence of in vivo interaction 
between Csr2 and Hxt6 (Fig.  3  A). The N- and C-terminal 
fragments (VN and VC) of the Venus fluorescent protein 
were fused to the C termini of Csr2 and Hxt6, respectively. 
In these experiments, Hxt6 was tagged at its chromosomal 
locus to keep its endogenous regulation, whereas Csr2-VN 
was expressed from a centromeric (low-copy) plasmid and 
driven by the strong pTEF1 promoter (translation elongation 
factor-1A) because the endogenous expression level of Csr2 
was too weak for BiFC analysis (not depicted). Early after in-
ducing Hxt6 endocytosis by switching the cells to lactate me-
dium (30 min), a fluorescent signal appeared in cytoplasmic 
punctate structures, which was dependent on the expression 
of Csr2-VN (Fig. 3 A). This signal partially colocalized with 
endosomes, as determined by the use of the endocytic tracer 
FM4-64 (Vida and Emr, 1995; Fig. 3 B). A vacuole-localized 
fluorescence signal appeared over time and became the major 
localization of the complex 2 h after transfer to lactate me-
dium (Fig. 3 A). This may be caused by the irreversible recon-
stitution of the Venus protein upon interaction between Csr2 
and Hxt6 (Hu et al., 2002). In the endocytic mutant, vrp1Δ, 
the reconstituted Csr2-VN/Hxt6-VC fluorescent complex lo-
calized to the plasma membrane, suggesting that the lack of 
a plasma membrane–localized signal in WT cells may be due 
to the time required for the reconstituted Venus protein to be-
come fluorescent (Hu et al., 2002; Fig. 3 A). Of note, no cyto-
solic punctae were observed in the vrp1Δ mutant, suggesting 
that the latter originate solely from endocytosis. Thus, Csr2 
can interact in vivo with Hxt6 during its endocytosis.
Csr2, as a member of the ART family, was proposed 
to act as an adaptor protein for Rsp5 to mediate cargo ubiq-
uitylation (Lin et al., 2008; Nikko et al., 2008; Polo and Di 
Fiore, 2008; Nikko and Pelham, 2009). To study Hxt6 ubiqui-
tylation, we used an endocytosis-deficient strain (vrp1Δ) that 
favors the detection of ubiquitylated cargoes. Indeed, higher 
molecular mass species of Hxt6-GFP were readily observed 
in crude extracts of the vrp1Δ mutant, which were absent in 
the rsp5 mutant npi1 (see Fig.  1  C). Moreover, this smear 
was much less present in the double vrp1Δ csr2-1 mutant, 
suggesting that Csr2 might contribute to Hxt6 ubiquitylation 
(Fig.  3, C and D). This was confirmed by purifying, in de-
naturing conditions, all ubiquitylated proteins from vrp1Δ 
and vrp1Δ csr2-1 strains expressing polyhistidine-tagged 
ubiquitin. In the purified fraction of the vrp1Δ single mutant, 
higher molecular mass species of Hxt6-GFP were enriched 
over nonmodified Hxt6-GFP, but this was not the case in the 
vrp1Δ csr2-1 mutant (Fig. 3, E and F), showing that Csr2 pro-
motes Hxt6 ubiquitylation.
Figure 2. Csr2 regulates Hxt6 homeostasis 
in the context of a yeast colony. (A) Vertical 
transverse sections of a WT and a csr2-1 
colony expressing Hxt6-GFP and grown on 
glycerol-ethanol complete respiratory medium, 
obtained by two-photon confocal imaging. 
Two individual images spanning the width of 
the colonies were acquired and assembled 
after acquisition to generate the composite 
image shown. Bars, 100 µm. (B) Detailed 
views of the fluorescence at the margin of 
each colony. Bars, 10 µm. (C) Detailed view 
of the central region of the colonies. Two in-
dividual images spanning the height of the 
colonies were acquired and assembled after 
acquisition to generate the composite image 
shown. Bars, 10 µm. (D) Detailed view of U 
(upper) cells and lower L (lower) cells as dis-
played in C. Bars, 10 µm.
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Figure 3. Csr2 interacts with Hxt6 in vivo and promotes its ubiquitylation. (A) WT or vrp1Δ cells expressing endogenously tagged Hxt6-VC and either 
pTEF-driven VN alone (negative control) or VN fused to Csr2 were grown as indicated and imaged by fluorescence microscopy. (B) WT cells expressing 
endogenously tagged Hxt6-VC and pTEF-driven Csr2-VN were grown in glucose medium and transferred to lactate medium for 30 min. At t = 15 min, 
the endocytic tracer FM4-64 was added for 15 min before imaging. (C) Total cell lysates from vrp1Δ and vrp1Δ csr2-1 cells expressing Hxt6-GFP grown 
in the indicated conditions were immunoblotted. Brace, higher molecular mass species of Hxt6-GFP accumulate in the vrp1Δ. (D) Line-scan profile of the 
immunoblot displayed in C. Continuous line, vrp1Δ lane; dashed line, vrp1Δ csr2-1 lane. (E) vrp1Δ and vrp1Δ csr2-1 cells expressing endogenously 
tagged Hxt6-GFP and His6-tagged ubiquitin (Ub) were grown for 6 h in lactate medium, and ubiquitylated proteins were affinity-purified. Input (Inp) and 
ubiquitin-purified fractions (El.) were immunoblotted using anti-GFP and anti-ubiquitin (purification control) antibodies. exp., exposure. (F) Line-scan profile 
of the immunoblot displayed in E. Continuous line, vrp1Δ lane; dashed line, vrp1Δ csr2-1 lane.
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Csr2 targets other high-affinity glucose 
transporters for endocytosis in glucose-
depleted medium
We studied the localization of other glucose transporters 
(Hxt1-Hxt5) fused to GFP in cells grown during the exponen-
tial phase in glucose-containing medium and during adapta-
tion to a glucose-deprived medium (Fig. S2 A). Only Hxt1 
and Hxt3 were expressed in glucose medium, consistent with 
their function as low-affinity glucose transporters (Ko et al., 
1993; Reifenberger et al., 1997; Ozcan and Johnston, 1999). 
Incubation in lactate medium led to their endocytosis and deg-
radation (Fig. S2 A), in line with previous studies (Snowdon 
et al., 2009; Roy et al., 2014). However, their endocytosis and 
degradation were independent of Csr2 (Fig. 4, A–F), suggest-
ing a distinct regulation. Hxt5, which displays a moderate af-
finity toward glucose (Diderich et al., 2001), was expressed 
after transfer to lactate medium and accumulated at the plasma 
membrane over time (Fig. S2 A), consistent with its function 
in glucose uptake upon glucose recovery (Bermejo et al., 
2010). A fraction of Hxt5 was targeted to the vacuole and de-
graded 7–24 h after transfer to lactate medium, but again, this 
did not require Csr2 (Fig. S2, B–D).
In contrast, Hxt2 and Hxt4, which display a moderate to 
high affinity toward glucose, followed a similar regulation as 
Hxt6 and Hxt7. Both transporters were induced upon transfer 
to lactate medium and became endocytosed and degraded after 
a few hours in a Csr2-dependent fashion (Fig. S2 A and Fig. 4, 
G–L). Thus, Csr2 primarily targets high-affinity glucose trans-
port systems for endocytosis after glucose depletion.
Csr2 transcription is up-regulated in 
conditions that trigger endocytosis
We then investigated the mechanism whereby Csr2 coordinates 
transporter endocytosis with glucose availability, starting with 
a possible regulation of its expression (Khanday et al., 2002). 
Csr2 was barely detectable in extracts from cells grown in glu-
cose medium but became expressed within 2  h after transfer 
to lactate medium (Fig. 5 A). This correlated with an increase 
of more than 14-fold in CSR2 transcripts in lactate versus glu-
cose medium (Fig. 5 B). The use of a β-galactosidase reporter 
revealed that the CSR2 promoter was activated to a similar 
extent during glucose depletion (Fig.  5  C). Thus, CSR2 tran-
scription is induced in conditions that trigger the endocytosis of 
the cargoes it regulates.
CSR2 expression is regulated by 
glucose availability through the Snf1/
protein phosphatase 1 pathway and its 
downstream effectors Mig1 and Mig2
Many genes are repressed by glucose through a glucose-sens-
ing pathway composed of the yeast AMPK orthologue Snf1 and 
its counteracting protein phosphatase 1 complex (Glc7/Reg1; 
Gancedo, 2008; Zaman et al., 2009). In the snf1Δ mutant, the 
CSR2 promoter remained repressed upon glucose removal, 
whereas in the reg1Δ mutant, CSR2 was constitutively dere-
pressed despite the presence of glucose (Fig. 5 D). Thus, the kinase 
Snf1 is required for the glucose-mediated repression of CSR2.
The Snf1/protein phosphatase 1 (PP1) pathway controls 
the transcription of many genes through several transcriptional 
effectors (Broach, 2012). The transcriptional repressor Mig1 
is a target of Snf1 and is responsible for the glucose-mediated 
repression of many Snf1-regulated genes. Mig2 is another 
repressor that sometimes cooperates with Mig1 in this transcrip-
tional regulation (Westholm et al., 2008). We observed that the 
CSR2 promoter was strongly derepressed in the mig1Δmig2Δ 
double mutant, even in the presence of glucose, whereas none of 
the single mutants were affected (Fig. 5 E). Thus, the Snf1/PP1 
glucose signaling pathway regulates CSR2 at the transcriptional 
level as a function of glucose availability through the redundant 
action of its downstream effectors Mig1 and Mig2. Notably, the 
abundance of the Csr2 protein in these various mutants was in 
general agreement with the observed activity of the CSR2 pro-
moter (Fig. 5, F and G). Minor variations were observed, which 
may be due to additional layers of regulation such as translation 
rate or mRNA stability (Braun et al., 2015).
CSR2 overexpression does not trigger Hxt6 
endocytosis but increases its efficiency
To study the impact of the transcriptional regulation of 
CSR2 on Hxt6 endocytosis, we interfered with the endoge-
nous expression of CSR2 through the use of the strong TEF1 
promoter, leading to Csr2 expression in glucose medium 
(Fig. 6 A). Even though Csr2 expression was high in glucose 
medium and decreased upon transfer to lactate medium, it 
was always stronger than endogenously expressed Csr2. Csr2 
overexpression led to faster endocytosis and degradation of 
Hxt6 upon transfer of cells to lactate medium (Fig. 6, B–D) 
indicating that Csr2 overexpression contributes to the overall 
efficiency of Hxt6 endocytosis.
Unexpectedly, while studying the nutritional signals 
responsible for Hxt6 endocytosis, we found that Hxt6 was 
endocytosed when cells were transferred to a medium con-
taining lactate or ethanol or even to a medium lacking any 
carbon source (see Fig.  1  B), but not when transferred to 
raffinose-containing medium (Fig. 6 E). Raffinose is a trisac-
charide that is slowly hydrolyzed in the medium by invertase, 
a secreted enzyme, into melibiose and fructose, only the lat-
ter of which can be used as a carbon source (Lindegren et 
al., 1944). Raffinose medium is thus sensed by yeast cells as 
containing a low hexose concentration (2% raffinose concen-
tration being equivalent to 0.2% glucose; Ozcan and Johnston, 
1995; Kim et al., 2003). In these conditions, Hxt6 mediates 
hexose uptake (Liang and Gaber, 1996) and is maintained at 
the plasma membrane (Fig. 6 E). Yet Csr2 was expressed in 
these conditions (Fig.  6  F). Therefore, although Csr2 is es-
sential for Hxt6 endocytosis, its expression is not sufficient to 
trigger transporter endocytosis. This reveals the existence of 
another level of regulation of Hxt6 endocytosis, possibly by 
the availability of substrates and/or its transport activity.
Ubiquitylation as a second level of 
regulation of Csr2 by glucose availability
The Csr2 protein migrated as a doublet by Western blot 
(Fig. 5, A, F, and G). ART proteins are ubiquitylated by Rsp5 
(Lin et al., 2008; Becuwe et al., 2012a), and Csr2 is an in 
vitro substrate of Rsp5 (Kee et al., 2006), raising the possi-
bility that this pattern is due to Csr2 ubiquitylation. The pu-
rification of all ubiquitin conjugates from cells coexpressing 
3HA-tagged Csr2 and His6-tagged ubiquitin revealed that 
the slower migrating band corresponded to ubiquitin-modi-
fied Csr2 (Fig.  7  A). Consistently, this band was no longer 
detected in the hypomorphic rsp5 mutant npi1 (Fig.  7  B) 
or upon mutations of proline-tyrosine (PY) motifs on Csr2, 
which are canonical sites predicted to interact with Rsp5 
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Figure 4. The endocytosis of other high-affinity hexose transporters during glucose deprivation also involves Csr2. (A) WT and csr2Δ cells expressing 
endogenously tagged Hxt1-GFP were grown as indicated and imaged for GFP fluorescence. (B) Total cell lysates from the experiment presented in A were 
immunoblotted using the indicated antibodies. (C) Western blot signals were quantified using ImageJ (n = 3 independent experiments); the ratio of the free 
GFP signal over the total GFP signal (±SEM) is represented (for the 4-h lactate time point). (D) WT and csr2Δ mutant cells expressing endogenously tagged 
Hxt3-GFP were grown as indicated and imaged for GFP fluorescence. (E) Total cell lysates from the experiment presented in D were immunoblotted using 
the indicated antibodies. (F) Western blot signals were quantified (± SEM) as in C (n = 3 independent experiments; NS, not significant). (G) WT and csr2Δ 
cells expressing endogenously tagged Hxt2-GFP were grown as indicated and imaged for GFP fluorescence. (H) Total cell lysates from the experiment 
presented in G were immunoblotted using the indicated antibodies. (I) Western blot signals were quantified (± SEM) as in C using the 7-h lactate time point 
(n = 3 independent experiments; **, P < 0.01). (J) WT and csr2-1 cells expressing endogenously tagged Hxt4-GFP were grown as indicated and imaged 
for GFP fluorescence. (K) Total cell lysates from the experiment presented in J were immunoblotted using the indicated antibodies. (L) Western blot signals 
(± SEM) were quantified as in C using the 7-h lactate time point (n = 3 independent experiments; **, P < 0.01).
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(Csr2-PYm: Y796A, Y1116A; Fig. 7 C). Thus, the upper band of 
the Csr2 doublet results from its ubiquitylation by Rsp5.
Strikingly, this ubiquitylated fraction of Csr2 vanished 
upon glucose treatment (Fig. 7, B and C). This was confirmed 
by an unbiased proteomics approach in which Csr2 was iden-
tified as a protein whose ubiquitylation is influenced by glu-
cose availability (Fig. 7, D and E). In conclusion, in addition 
to the transcription-based regulation of CSR2, this dynamic 
ubiquitylation represents a second glucose-regulated event in 
the regulation of Csr2.
Glucose treatment led not only to loss of Csr2 ubiquityl-
ation but also to the rapid disappearance of Csr2 (Fig. 7, B and 
C). 3HA-tagged Csr2 is a short-lived protein, with a compara-
ble half-life in lactate and glucose medium (Fig. S3, A and B), 
suggesting that its disappearance in response to glucose does 
not involve a glucose-induced degradation process but rather 
is due to a transcriptional shutdown of CSR2 followed by the 
degradation of preexisting Csr2. This degradation involved the 
proteasome: treatment of cells with the proteasome inhibitor 
MG-132 led to Csr2-3HA stabilization, in a nonubiquitylated 
state after glucose addition (Fig. S3 A). However, this degrada-
tion did not require Rsp5, because Csr2 was degraded at com-
parable levels in the npi1 mutant or upon mutation of its PY 
motifs (Fig. 7, B and C). This suggests the involvement of an 
additional ubiquitin ligase. However, we did not pursue this line 
of investigation. Indeed, Csr2 stability was influenced by the 
epitope used for tagging; for instance, a tandem affinity purifi-
cation (TAP; = calmodulin binding protein–TEV–protein A)–
tagged version of Csr2 caused a much slower degradation after 
glucose treatment (Fig. S3 C).
Csr2 ubiquitylation occurs on a conserved 
lysine of the arrestin-C domain and is 
required for its function in endocytosis
Initial studies reported that the ubiquitylation of ARTs promotes 
their activation (MacGurn et al., 2011; Becuwe et al., 2012b; 
Merhi and André, 2012; Karachaliou et al., 2013). Yet some 
ARTs can mediate endocytosis independently of their ubiqui-
tylation (Alvaro et al., 2014; Crapeau et al., 2014). As a first 
step to understanding whether Csr2 ubiquitylation contributes 
to high-affinity glucose transporter endocytosis, we mapped the 
ubiquitylation site. Mass spectrometry analysis of a Csr2-3HA 
immunoprecipitate identified one Csr2 peptide that contained 
a ubiquitin remnant motif on residue K670 (K-ε-GG signature; 
Peng et al., 2003; Fig. S4 A). This residue was located at the be-
ginning of the predicted arrestin-C domain and is conserved in 
at least seven other yeast ART proteins (Fig. 8 A). In particular, 
it is included among the four sites whose mutation abolished 
Rod1 ubiquitylation (Becuwe et al., 2012b). Mutation of this 
site (K670R) abolished Csr2 ubiquitylation (Fig. 8 B). Thus, Csr2 
is ubiquitylated on a conserved residue of the arrestin-C domain 
upon glucose deprivation. Importantly, the Csr2(KR)-3HA mu-
tant was degraded similarly to WT Csr2-3HA after glucose 
treatment (Fig. 8 B), further confirming that the Rsp5-mediated 
ubiquitylation of Csr2-3HA does not regulate its stability.
The Csr2(KR) mutant could not restore Hxt6-GFP en-
docytosis, nor its degradation (Fig.  8, C and D, and Fig. S4 
B) when expressed on a csr2-1 background. Therefore, Csr2 
ubiquitylation is essential for its function in endocytosis in 
glucose-depleted conditions. Consequently, the loss of Csr2 
ubiquitylation upon glucose replenishment probably leads to its 
Figure 5. Glucose represses CSR2 expression. 
(A) Cells expressing endogenously tagged 
Csr2-3HA were grown as indicated, and 
total cell lysates were immunoblotted with the 
indicated antibodies. Lact, lactate. (B) Total 
RNA was prepared from cells that are WT for 
CSR2, and the CSR2 transcript was detected 
by quantitative RT-PCR. Data represent 
the mean of four independent biological 
replicates (each with two technical replicates) 
± SEM. (C) β-Galactosidase activity of cells 
expressing the lacZ reporter gene driven by 
the CSR2 promoter, grown as indicated. Data 
were normalized to β-galactosidase activity 
in glucose-grown cells and are the mean of 
three independent biological replicates (each 
with three technical replicates) ± SEM. (D) 
β-Galactosidase activity (± SEM) of WT, snf1Δ, 
and reg1Δ cells expressing the pCSR2 :lacZ 
fusion. (E) β-Galactosidase activity (± SEM) of 
WT, mig1Δ, mig2Δ, and mig1Δ mig2Δ cells 
expressing the pCSR2 :lacZ fusion. (F) WT, snf1Δ, 
and reg1Δ cells expressing endogenously 
tagged Csr2-3HA grown as indicated, and 
total cell lysates were immunoblotted with 
anti-HA and anti-PGK antibodies. (G) WT and 
mig1Δ mig2Δ cells expressing endogenously 
tagged Csr2-3HA grown as indicated, and 
total cell lysates were immunoblotted with 
anti-HA and anti-PGK antibodies.
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inactivation. Interestingly, Csr2(KR)-VN still interacted with 
Hxt6-VC by BiFC, suggesting that Csr2 ubiquitylation is not a 
prerequisite for this interaction (Fig. 8 E).
Phosphorylatable sugars regulate Csr2 
ubiquitylation
To probe the signaling events whereby glucose regulates Csr2 
ubiquitylation, we studied the effect of other sugars or glucose 
analogues. Fructose (which, like glucose, is a substrate of hex-
okinase and is metabolized by glycolysis) and sucrose (which 
is hydrolyzed in the extracellular medium into glucose and 
fructose by invertase) were equally as competent as glucose to 
mediate a change in Csr2 ubiquitylation (Fig. 9 A). The glu-
cose analogue 2-deoxyglucose, which is also phosphorylated by 
hexokinase but cannot be further metabolized, also elicited the 
loss of Csr2 ubiquitylation (Fig. 9 B). In contrast, 3-O-meth-
ylglucose, which behaves as a nonphosphorylatable sugar, 
did not alter the Csr2 ubiquitylation pattern (Fig. 9 B). Csr2 
ubiquitylation is therefore regulated by sugar phosphorylation 
during early steps of glycolysis, independently of the energy 
provided by sugar metabolism.
Interestingly, when expressed in glucose medium using 
the pTEF promoter, Csr2 was still ubiquitylated, albeit to a 
lesser extent than the endogenous Csr2 in lactate medium (see 
Fig. 6 A). This indicates that the loss of Csr2 ubiquitylation is 
part of an early glucose response. This is further supported by 
our observation that the loss of Csr2-TAP ubiquitylation after 
glucose treatment was only transient (see Fig. S3 C).
Figure 6. The transcriptional regulation of Csr2 contributes to the timing of Hxt6 endocytosis. (A) Cells expressing endogenously 3HA-tagged Csr2 driven 
by its endogenous promoter or the strong TEF1 promoter were grown as indicated, and total cell lysates were immunoblotted with the indicated antibodies. 
(top) Samples were on the same gel and exposed for the same amount of time. Middle, longer exposure. (B) Localization of endogenously GFP-tagged Hxt6 
in cells expressing Csr2, driven either by its endogenous promoter or by the TEF promoter, grown as indicated. (C) Total cell lysates prepared from the ex-
periment depicted in B were immunoblotted with the indicated antibodies. (D) Western blots signal were quantified using ImageJ (n = 3 independent exper-
iments); the ratio of the free GFP signal over the total GFP signal at various time points is represented ± SEM (*, P < 0.05). Diamonds, WT strain; triangles, 
pTEF-CSR2 strain. (E) Localization of Hxt6-GFP in WT cells grown in glucose medium and switched to the indicated media. (F) Cells expressing endogenously 
3HA-tagged Csr2 driven by its endogenous promoter were grown as indicated, and total cell lysates were immunoblotted with the indicated antibodies.
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Ubp2 controls the topology of the ubiquitin 
modification on Csr2
We then aimed to dissect the mechanism responsible for the dy-
namic, glucose-regulated ubiquitylation of Csr2. Previous work 
demonstrated that Rsp5 physically interacts with Ubp2, a deubiq-
uitylating enzyme that counteracts Rsp5 activity in the assembly 
of K63-linked ubiquitin chains (Kee et al., 2005). Additionally, 
in vitro ubiquitylated Csr2 was also a substrate of Ubp2 (Kee et 
al., 2006). However, the deletion of UBP2 only mildly affected 
the loss of Csr2 ubiquitylation in response to glucose (Fig. 9 C). 
Yet in lactate-grown ubp2Δ cells, a fraction of Csr2 was shifted 
up in its apparent size (Fig. 9 C). This may be due to increased 
ubiquitylation of Csr2, in line with the proposed role of Ubp2 in 
controlling ubiquitin chain length on Rsp5 substrates (Kee et al., 
2005, 2006; Harreman et al., 2009; Erpapazoglou et al., 2012). 
Indeed, overexpression of a ubiquitin mutant unable to generate 
K63-linked chains (ubiquitin-K63R) interfered with this process 
and restricted the extent of this shift (Fig. 9 D). Thus, Ubp2 con-
trols the extent of the K63-linked ubiquitin chain length generated 
by Rsp5 on Csr2. We further looked for the possible involvement 
of other deubiquitylating enzymes in Csr2 deubiquitylation upon 
glucose treatment, using single or multiple ubiquitin isopepti-
dase mutants because a level of redundancy was anticipated from 
previous studies (Amerik et al., 2000). However, the disappear-
ance of ubiquitylated Csr2 in response to glucose was maintained 
in all of the mutants studied (unpublished data).
Glucose-regulated deubiquitylation 
of Csr2 involves its phosphorylated 
N-terminal region
ART ubiquitylation can be negatively regulated by their phos-
phorylation (Becuwe et al., 2012b; Merhi and André, 2012). We 
identified several phosphorylation sites (serine [Ser]/threonine 
[Thr]) by mass spectrometry after immunoprecipitation of Csr2-
3HA. Most of them clustered within two regions of the protein 
(i.e., around residues 1–150 and 950–990; Fig. 10 A). To inves-
tigate whether these contribute to the regulation of Csr2 ubiqui-
tylation, we deleted the first 150 residues of Csr2 (Csr2-Δ150). 
Csr2-Δ150 was functional and restored Hxt6-GFP endocytosis 
when expressed in a csr2-1 mutant (see Fig. S5 A) but remained 
ubiquitylated even after the addition of glucose (Fig. 10 B, lane 
8). This became even more evident upon stabilization of the pro-
tein with MG-132: whereas Csr2 was stabilized as a nonubiqui-
tylated protein, Csr2-Δ150 was stabilized as both ubiquitylated 
and nonubiquitylated (Fig. 10 B, compare lanes 6 and 12). This 
ubiquitylation still occurred on K670, as determined by the lack 
of ubiquitylation of a Csr2-Δ150, K670R mutant (Fig. S5 B).
The mutation of some of the phosphorylated Ser/Thr 
residues located in this region into alanine (see Materials and 
methods) recapitulated the Csr2Δ150 mutation, because the 
Csr2-S/T-A mutant was still functional for endocytosis (Fig. 
S5, C and D) but was no longer deubiquitylated after glucose 
treatment (Fig. 10 C). This suggests that the glucose-induced 
deubiquitylation of Csr2 is an active process that involves the 
phosphorylation of its N-terminal Ser/Thr residues.
PKA activity regulates the glucose-
mediated deubiquitylation of Csr2
To identify the potential kinase involved in this regulation, we 
screened 23 mutants from the deletion collection library on the 
basis of previous data that predicted kinases that may phosphor-
ylate Csr2 (Mok et al., 2010; Fig. S5 E). Both Tpk1 and Tpk3, 
which are two of the three alternative catalytic subunits of yeast 
PKA, were also predicted to phosphorylate Csr2, but because 
of the described redundancy between these proteins (Broach, 
2012), they were not included in this analysis. Instead, we stud-
ied the effect of the deletion of the PKA regulatory subunit, 
which is encoded by a single gene, BCY1 (Toda et al., 1987).
Figure 7. Csr2 ubiquitylation is regulated by 
glucose availability. (A) Purification of ubiqui-
tylated proteins from cells coexpressing Csr2-
3HA and histidine-tagged ubiquitin and grown 
in lactate medium for 4  h.  Lys, lysate; Unb, 
unbound fraction; El, eluates. Protein extracts 
were immunoblotted with the indicated anti-
bodies. (B) WT and npi1 (rsp5 mutant) cells 
expressing endogenously 3HA-tagged Csr2 
were grown in glucose medium and switched 
to lactate-containing medium for 4  h, before 
glucose was added back. Total cell lysates 
were prepared and immunoblotted with the 
indicated antibodies. (C) WT cells expressing 
a plasmid-encoded Csr2-3HA or its mutated 
variant, Csr2(PYm)-3HA (mutations Y796A 
and Y1116A) were grown and processed as 
in B.  (D) Design of the quantitative proteom-
ics experiment. Lactate-grown cells expressing 
His6-tagged ubiquitin were treated or not with 
2% glucose for 10 min. Ubiquitylated proteins 
were then purified in both conditions, identi-
fied and quantified by quantitative, label-free 
mass spectrometry. LC-MS/MS, liquid chroma-
tography–tandem mass spectrometry. (E) Vol-
cano plot displaying the log2 value of the ratio 
of protein abundance (label-free quantification 
[LFQ] intensity) in the presence or absence of 
glucose, plotted against −log10 of the p-value 
of the t test for each protein (four independent 
biological replicates). The line indicates the 
threshold for a 5% false discovery rate.
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The deletion mutants were transformed with a plasmid 
encoding Csr2-TAP, and its migration pattern was evaluated 
by Western blotting before and after glucose addition in each 
strain. Csr2 displayed an unusual migration pattern in the bcy1Δ 
strain, because it migrated as a single band rather than a doublet 
(Fig. S5 E and Fig. 10 D). Because Bcy1 inhibits PKA activity, 
the sustained PKA activity in the bcy1Δ mutant might cause a 
constitutive deubiquitylation of Csr2, even in lactate medium. 
Accordingly, mutations of the N-terminal Ser/Thr residues, or 
deletion of this region (Δ150), restored a normal, ubiquitylated 
pattern of Csr2 in the bcy1Δ strain (Fig. 10 D and Fig. S5 F). 
This suggests that the PKA-mediated phosphorylation of the 
N-terminal part of Csr2 may regulate ubiquitylation. This was 
confirmed by using a PKA mutant (pkaas) in which the TPK1, 
Figure 8. Csr2 is ubiquitylated at a conserved site in the ART proteins and this is required for its function in endocytosis. (A, top) Schematic of the primary 
structure of the Csr2 protein showing potential arrestin-N domain (Becuwe et al., 2012a), arrestin-C domain (Pfam accession no. PF02752), LPxY and 
PPxY motifs, and the lysine residue identified as ubiquitylated by mass spectrometry (K670; see Fig. S4 A). (bottom) Partial alignment of seven ART proteins 
from S. cerevisiae showing the conservation of a lysine residue at this position. Arrowheads, residues whose combined mutation abolishes Rod1 ubiquityl-
ation (Becuwe et al., 2012b). (B) Total cell lysates from WT cells expressing a plasmid-encoded Csr2-3HA or its mutated variant, Csr2(KR)-3HA (mutation 
K670R) were prepared at the indicated times and immunoblotted with the indicated antibodies. (C) Localization of Hxt6-GFP in WT cells (carrying an empty 
plasmid) and csr2-1 mutant cells, transformed with either an empty plasmid, a plasmid carrying a WT Csr2-3HA, or the point mutant Csr2(KR)-3HA in the 
indicated growth conditions. (D) From the experiment depicted in C, total cell lysates were prepared and immunoblotted (see a representative immunoblot 
in Fig. S4 B). GFP signals were quantified at various time points and are plotted ± SEM (n = 3 independent experiments); p-values were calculated for 
the 7-h time point (***, P < 0.001). (E) WT cells expressing both endogenously tagged Hxt6-VC and either a pTEF-driven Csr2-VN or a pTEF-driven Csr2-
KR-VN were grown in glucose medium and switched to lactate medium for 30 min. Csr2-KR-VN-expressing cells were labeled with the vacuolar dye CMAC, 
washed, and mixed with Csr2-VN-expressing cells. Both strains were imaged together by fluorescence microscopy in the green and blue channels. (left) 
Detailed view of the indicated cells.
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TPK2, and TPK3 genes were replaced by their corresponding 
ATP-analogue sensitive mutant alleles (Zaman et al., 2009). 
The chemical inhibition of PKA in this strain using the ATP 
analogue 1NM-PP1 revealed that Csr2 was no longer deubiq-
uitylated upon glucose replenishment (Fig. 10 E). Of note, the 
addition of glucose to cells grown in nonfermentable carbon 
sources was previously reported to induce a spike in cyclic AMP, 
in line with an activation of PKA in these conditions (Kraakman 
et al., 1999). This is further supported by the observation that 
Msn2-GFP, a transcription factor whose nuclear/cytosolic par-
titioning is regulated by PKA, relocates to the cytosol during 
the lactate/glucose transition (Fig. S5 G). Altogether, these data 
reveal a novel role for PKA in controlling the glucose-induced 
deubiquitylation of Csr2.
Csr2 dynamically interacts with the 14-3-
3 proteins Bmh1 and Bmh2
Previous work on ART proteins revealed that cross-talk be-
tween phosphorylation and ubiquitylation sometimes involves 
the yeast 14-3-3 proteins Bmh1 and Bmh2 (Becuwe et al., 
2012b; Merhi and André, 2012). A proteomic study identified 
many ARTs among the Bmh1/2 interactants, including Csr2 
(Kakiuchi et al., 2007). Moreover, Csr2 possesses a type I 14-
3-3 binding site (consensus Rxx[pS/T]xP) at residue S103, 
which we found to be phosphorylated in vivo. Using coimmu-
noprecipitations, we found that Csr2 bound endogenous Bmh1 
and Bmh2, especially after glucose treatment (Fig. 10 F). This 
interaction depended on the phosphorylated residues in Csr2 N 
terminus, because their mutation disrupted the interaction with 
Bmh1/2 (Fig. 10 F). Because these N-terminal residues are also 
involved in Csr2 deubiquitylation, we speculate that upon glu-
cose treatment, an increased, phospho-dependent binding of 
Csr2 to 14-3-3 proteins could lead to Csr2 deubiquitylation and 
thus its inactivation. In support of this hypothesis, Rsp5 inter-
acted with Csr2 regardless of the presence of glucose, showing 
that the loss of ubiquitylation of Csr2 in these conditions is not 
due to its lack of interaction with Rsp5.
Discussion
In this study, we discovered a role for the poorly characterized 
ART protein Csr2 in transporter endocytosis upon glucose depri-
vation. We reveal that Csr2 selectively regulates the endocytosis 
Figure 9. Regulation of Csr2 ubiquitylation by sugar analogues and the ubiquitin-specific protease Ubp2. (A) Lactate-grown WT cells expressing endoge-
nously tagged Csr2-3HA were treated with glucose, fructose, or sucrose or were nontreated (lactate). Total cell lysates were prepared and immunoblotted 
with the indicated antibodies. (B) Same as A, except that cells were treated with 2-deoxyglucose (2-DG) or 3-O-methylglucose (3-O-MG). (C, top) Total cell 
lysates from WT and ubp2Δ cells expressing endogenously tagged Csr2-3HA and grown as indicated were immunoblotted with anti-HA and anti-PGK 
antibodies. (bottom) Line scan showing band intensity as a function of the distance from the maximum of the indicated non-Ub Csr2 peak. (D, top) Total cell 
lysates from ubp2Δ cells expressing endogenously tagged Csr2-3HA and overexpressing either WT ubiquitin or K63R-ubiquitin were grown and treated as 
in C. (bottom) Line scan was performed as in C. Arrows on the right indicate the position of nonubiquitylated, ubiquitylated, and polyubiquitylated Csr2.
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Figure 10. Mechanism of glucose-induced deubiquitylation of Csr2. (A) Schematic of the primary sequence of Csr2 indicating, in green, the position of 
phosphorylated sites identified by mass spectrometry on a Csr2-3HA immunoprecipitate. (B) Glucose-grown cells expressing a plasmid-encoded full-length 
Csr2-3HA or a construct lacking its first 150 residues (Csr2-Δ150-3HA; pdr5Δ background) were switched to lactate-containing medium. Cells were then 
treated with MG-132 (lanes 4 and 10) or not (lanes 1 and 7) for 30 min before glucose was added (lanes 2 and 3, 5 and 6, 8 and 9, and 11 and 12). 
Total cell lysates were prepared and immunoblotted with the indicated antibodies. (C) WT cells expressing an HA-tagged, plasmid-encoded Csr2-3HA or 
mutated for several Ser/Thr residues were grown as indicated, and total cell lysates were immunoblotted with the indicated antibodies. (D) WT or bcy1Δ 
cells expressing either a plasmid-encoded Csr2-TAP or Csr2-(S/T-A)-TAP were grown as indicated, and total cell lysates were immunoblotted using peroxi-
dase anti-peroxidase (PAP) and anti-PGK antibodies. (E) The PKA mutant strain (pkaas) or its WT control, both expressing a Csr2-TAP construct, were grown 
overnight in glucose medium (exponential phase) and transferred to lactate medium for 4 h in the presence of either 50 µM 1NM-PP1 or an equivalent 
volume of DMSO. Then, glucose was added to the culture. Total cell lysates were prepared and immunoblotted using the indicated antibodies. (F) WT 
cells carrying an empty vector, a vector encoding Csr2-TAP or Csr2-(S/T-A)-TAP were grown in lactate-containing medium, before glucose was added. 
Cells were lysed (inputs) and TAP constructs were affinity-purified (eluates). The presence of Csr2 was revealed using PAP antibodies and that of Bmh1/2 
and Rsp5 using specific antibodies. (G) Working model for the regulation of Csr2 by glucose availability. Left: In the absence of glucose, activation of the 
yeast AMPK kinase Snf1 inhibits the Mig1/Mig2 repressors causing CSR2 derepression. Csr2 is constitutively ubiquitylated by Rsp5 on a conserved lysine, 
and ubiquitin chain elongation is counteracted by Ubp2. Right: Upon addition of glucose to the medium, Mig1/Mig2 repress CSR2 transcription. This is 
accompanied by an increased, phospho-dependent association of Csr2 with the Bmh1/2 proteins (14-3-3), along with its deubiquitylation, which requires 
protein kinase A. Note that Csr2 is also subject to proteasomal degradation (not depicted).
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of medium- to high-affinity hexose transporters, namely, Hxt2, 
Hxt4, Hxt6, and Hxt7. Csr2 was previously involved in Hxt6 
endocytosis in stress conditions, which may represent a sepa-
rate function (Nikko and Pelham, 2009). Endocytosis of high- 
and low-affinity hexose transporters upon glucose limitation 
occurs with different kinetics and likely results from different 
physiological inputs. The endocytosis of Hxt1 and Hxt3 likely 
corresponds to the removal of transporters that, because of their 
low affinity for glucose, are not appropriate when glucose is 
scarce. This regulation involves the Ras/cAMP-PKA pathway 
(Snowdon et al., 2009; Snowdon and van der Merwe, 2012; 
Roy et al., 2014). Instead, we propose that the endocytosis of 
high-affinity hexose transporters is triggered when they lack 
substrates to transport. Our results demonstrate that Csr2 is 
central to the second strategy only. Overall, our findings bolster 
the idea that ARTs target a limited set of transporters in a given 
physiological situation.
Although a defect in hexose transporters endocytosis 
should not impair viability, failure to do so may slow down ad-
aptation and decrease cell fitness. The clearance of inadequate 
transporters from the plasma membrane could facilitate the in-
sertion of neosynthesized transporters, and their degradation 
could provide metabolic intermediates required to cope with 
glucose exhaustion (as described in the case of N starvation, in 
which transporter endocytosis and degradation provide nitrogen 
to allow the onset of autophagy; Müller et al., 2015). This will 
be the focus of future studies. Finally, Hxt6 endocytosis also oc-
curred in the context of yeast colony differentiation, suggesting 
that a Csr2-dependent hexose transporter remodeling occurs in 
this particular physiological condition.
We report the multiple levels at which Csr2 is regulated by 
glucose availability (see proposed working model in Fig. 10 G). 
Glucose represses CSR2 transcription through the yeast AMPK 
orthologue Snf1 and its downstream transcriptional repressors 
Mig1 and Mig2. Prior evidence from a high-throughput tran-
scriptomics study suggested that the PP1 phosphatase (Glc7/
Reg1), which counteracts Snf1 activity, negatively regulated 
CSR2 expression (Apweiler et al., 2012), in accordance with our 
observations. Thus, the transcriptional control of ART expression 
participates in the regulation of endocytosis. A glucose-indepen-
dent, proteasome-mediated degradation of Csr2 superimposes 
on this transcriptional regulation but was independent of Rsp5, 
suggesting the involvement of another ubiquitin ligase in this 
mechanism and arguing against a preferential degradation of 
active Csr2 species. Because Csr2 is already deubiquitylated 
and presumably inactive, this degradation step is likely to be of 
minor significance for the regulation of endocytosis. However, 
it may be important for the homeostasis of ART proteins, which 
compete with one another for interaction with Rsp5.
Of note, the transcriptional induction of CSR2 in glu-
cose-starvation conditions was not sufficient to trigger Hxt6 
endocytosis. Numerous studies have pointed to a role of sub-
strate binding and/or transport in regulating transporter traffick-
ing (Blondel et al., 2004; Jensen et al., 2009; Cain and Kaiser, 
2011; Keener and Babst, 2013; Ghaddar et al., 2014; Roy et al., 
2015). Although the nature of the signal that sets off high-af-
finity glucose transporter endocytosis in the absence of glucose 
will need to be further explored, hexose binding and/or trans-
port could behave as a protective signal against high-affinity 
glucose transporter endocytosis.
An additional glucose-mediated regulation of Csr2 oc-
curred at the posttranslational level. Csr2 ubiquitylation at a 
conserved site in the arrestin-C domain was required for its 
function in endocytosis. Proteomic database searches revealed 
that this residue is the major ubiquitylation site for nearly all 
ART proteins (Craig et al., 2004). Although the mechanism by 
which ART ubiquitylation regulates their function remains to 
be investigated, we reveal for the first time, using BiFC, that 
it is not essential for cargo interaction. Moreover, we found 
that Csr2 was deubiquitylated upon glucose addition to the me-
dium, likely causing its inactivation (Fig. 10 G), at a time when 
endocytosis is relayed by the glucose-activated ART protein 
Rod1 (Nikko and Pelham, 2009; Becuwe et al., 2012b; Llopis- 
Torregrosa et al., 2016). It is interesting to note that Rsp5 still 
interacted with Csr2 after glucose addition (i.e., when Csr2 is 
no longer ubiquitylated), supporting the idea of an active deu-
biquitylation event. However, the enzyme involved could not 
be identified at this stage. Functional redundancies and over-
laps within ubiquitin isopeptidases can compromise the identi-
fication of their function by genetic approaches (Amerik et al., 
2000; Kouranti et al., 2010; Weinberg and Drubin, 2014).
The glucose-induced deubiquitylation of Csr2 required its 
N-terminal region, particularly Ser/Thr residues that we identi-
fied as phosphorylated. PKA appeared as a negative regulator 
of Csr2 ubiquitylation, and this depended on the integrity of 
Csr2 phospho-residues. These data, together with an apparent 
activation of PKA during the lactate/glucose shift, lead us to 
suggest that PKA may directly phosphorylate residues in the 
N-terminal region of Csr2 in these conditions, thereby partic-
ipating to the deubiquitylation/inactivation process. However, 
this remains to be formally proved.
A dynamic interaction of ARTs with the 14-3-3 proteins 
Bmh1/Bmh2 was previously implicated in the regulation of ART 
ubiquitylation (Becuwe et al., 2012b; Merhi and André, 2012). 
In these studies, 14-3-3 proteins were proposed to hinder ART 
ubiquitylation by Rsp5, and thus to keep them in an inactive 
state, until the interaction is released. Strikingly, we report here 
the reversal of this mechanism, in which Bmh1/Bmh2 binding 
to the N-terminal phosphorylated residues of Csr2 is concom-
itant to Csr2 deubiquitylation. A unifying model could be that 
14-3-3 binding leads to a constitutive deubiquitylation of ART 
proteins, maybe by favoring the recruitment of deubiquitylat-
ing enzymes. This will be the subject of future investigations. 
Yet our results consolidate the paradigm of a nutrient-regulated 
phosphorylation/ubiquitylation crosstalk on ART proteins in the 
control of transporter endocytosis.
Our study completes previous work on the involvement of 
the yeast AMPK orthologue, Snf1, in carbon source transport-
ers homeostasis (Becuwe et al., 2012b; O’Donnell et al., 2015). 
The Snf1/PP1 nexus channels glucose presence or absence 
signals through various ART proteins so that cells efficiently 
adapt to glucose fluctuations. Additionally, the contribution of 
PKA activity in Csr2 inactivation by glucose also reveals an 
unprecedented cross-talk of these two signaling pathways in the 
regulation of endocytosis.
Although the regulation of nutrient transporter endocytosis 
by extracellular nutrients remains marginally studied in mam-
malian cells, GLUT1 availability at the cell surface is regulated 
by glucose starvation via AMPK and the arrestin-related pro-
tein TXN IP (Wu et al., 2013). This striking conservation reveals 
that similar regulatory mechanisms are at stake in the regulation 
of transporter endocytosis in mammalian cells. These results 
have important consequences when addressing the molecular 
basis of several pathologies. TXN IP is an important metabolic 
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regulator, particularly of glucose and lipid metabolism (Parikh 
et al., 2007; Patwari and Lee, 2012; Shen et al., 2015; Doti-
mas et al., 2016). TXN IP acts as a tumor suppressor in a mouse 
model of thyroid cancer: its overexpression causes a reduction 
of cellular glucose influx and impairs cell migration (Morrison 
et al., 2014), whereas TXN IP deficiency is linked to the appear-
ance of hepatocellular carcinomas (Sheth et al., 2006). Another 
arrestin-related protein, ARR DC3, is linked to obesity in mice 
and humans (Patwari et al., 2011; Patwari and Lee, 2012) and, 
through its role in the endocytosis of β4 integrin, also acts as a 
tumor suppressor (Draheim et al., 2010). Thus, future studies 
should focus on reaching a better understanding of the function 
and the regulation of arrestin-related protein by metabolism to 
form the basis of new therapeutic approaches.
Materials and methods
Yeast strains, transformation, and growth conditions
Strains are listed and detailed in Tables S1 and S2. All strains are 
derivatives of the BY4741/2 strains unless otherwise indicated. The 
9-arrestinΔ mutant was provided by H.  Pelham (Medical Research 
Council Laboratory of Molecular Biology, Cambridge, England, UK; 
Nikko and Pelham, 2009). Yeast was transformed by standard lithium 
acetate/polyethylene glycol procedure. Gene deletion and tagging were 
performed by homologous recombination and confirmed by PCR on 
genomic DNA. This was critical because several HXT genes display a 
strong sequence homology at the DNA level, which sometimes leads to 
mistargeting of the tagging cassette. Throughout this study, transporters 
were tagged at the chromosomal locus by homologous recombination, 
and their expression was driven by their endogenous promoter.
The csr2-1 mutant was generated by inserting a KanMax cas-
sette preceded by a stop codon at +45 bp relative to the CSR2 start 
codon. This was necessary because in the csr2Δ strain, several HXTs 
showed an aberrant expression level that could not be linked to 
CSR2 function (Fig. S1).
Cells were grown in yeast extract/peptone/glucose–rich medium 
or in synthetic complete (SC) medium (yeast nitrogen base 1.7 g/liter 
[MP Biomedicals], ammonium sulfate 5 g/liter [Sigma-Aldrich], and 
dropout amino acid solutions [Elis Solutions]) containing 2% (wt/vol) 
glucose or 0.5% (vol/vol) sodium-lactate, pH 5.0 (Sigma-Aldrich). 
For the growth protocol, cells were routinely grown overnight in 
SC-glucose medium (inoculation at absorbance at 600 nm [A600] 
= 0.001 in the evening), harvested in early exponential phase in the 
morning (A600 = 0.3–0.5), resuspended in the same volume of SC me-
dium containing 0.5% lactate (vol/vol), 2% raffinose (wt/vol), or water 
(no carbon source) as indicated and grown for the indicated times. For 
Csr2 deubiquitylation analysis (Fig. 9, A and B), 2% glucose (or the 
indicated sugar at the indicated concentration) was added back to cells 
grown in SC-lactate medium. 2-Deoxyglucose and 3-O-methylglucose 
were purchased from Sigma-Aldrich and were used at final concentra-
tions of 0.2% and 2%, respectively.
Plasmids and constructs
The plasmids used in this study are listed in Table S3.
To obtain pSL168, the promoter region of CSR2 (912 bp) was 
amplified from genomic DNA (using oligonucleotides oSL437/
oSL438) and cloned BamHI–EcoRI upstream the lacZ gene into a 
Yep358-based vector (Lodi et al., 2002) to replace the JEN1 promoter.
The plasmid encoding untagged CSR2 was constructed by am-
plifying the CSR2 gene (−500 bp before ATG, +300 bp after stop 
codon) from genomic DNA using primers oSL713/oSL714 and cloning 
at XhoI–XbaI sites into pRS416. To obtain pSL324, a region containing 
the ECM21 promoter (−500 bp) and ORF was amplified from genomic 
DNA (using oligonucleotides oSL770/oSL751) and cloned SpeI–XhoI 
into pSL94 (Becuwe et al., 2012b) at SpeI–XhoI sites.
The plasmid encoding HA-tagged Csr2 under the control of its 
endogenous promoter (pSL308) was constructed using a 1-kb promoter 
region of CSR2 (from pSL172, a pRS416-based plasmid containing 
pCSR2 :GFP -CSR2) cloned at SacI–XbaI sites in place of the ADH 
promoter into pSL178 (pADH :CSR2 -3HA).
The K670R mutation in CSR2 was obtained by site directed mu-
tagenesis on pSL172 using oligonucleotides oSL715/oSL716, giving 
pSL314. The NheI–SalI fragment from pSL314 (containing the KR mu-
tation) was then cloned into pSL308 at NheI–SalI sites, giving pSL318.
The PYm mutations in CSR2 were obtained in two steps. A PCR 
product (oSL448/oSL656 using pSL172 as a template) was digested at 
BstEII–SalI and cloned at BstEII–XhoI sites in pSL172 to mutate the 
C-terminal PPRY motif of Csr2 (residues 1113–1116) into PPRA, giving 
pSL306. This was then mutagenized using oSL662/oSL663 to mutate 
the LPPY site (residues 793–796) into LPPA, giving pSL307. The XbaI–
SmaI fragment from pSL307 (containing the mutations) was then cloned 
into pSL311 (a pRS415-based plasmid containing pCSR2 :mcs -3HA).
For the N-terminal truncation (Δ150), plasmid pSL325 was gen-
erated by amplifying a truncated version of CSR2 (missing the first 
450 nucleotides; oSL768/oSL440) from pSL308 and cloning XbaI–
XhoI into pSL308-digested XbaI–XhoI to replace WT CSR2. Plasmid 
pSL345 was generated using a similar strategy: a truncated version of 
CSR2-KR (missing the first 450 nucleotides) was amplified (oSL768/
oSL440) from pSL318 and was cloned at XbaI–XhoI into pSL308- 
digested XbaI–XhoI to replace WT CSR2.
For the Ser–Thr mutations, a mutant version of CSR2 was ob-
tained by gene synthesis (MWG Eurofins; pSL350), digested at PstI–
PstI, and cloned PstI–PstI at endogenous CSR2 sites into pSL308, giving 
pSL351. The Ser/Thr sites mutated included some of those identified 
by mass spectrometry (underlined in the following text), and neighbor-
ing sites (≤2 residues in Nt or Ct of the modified residue) when pres-
ent: S42T43S44S46, S59S60S61, T72S75T77S78S79, S103, T116S118, S127, S148. All 
residues were mutated into alanine. The construct was expressed and 
functional for endocytosis, as shown in Fig. 10 and Fig. S5, C and D.
All constructs were checked by sequencing. The pCSR2-CSR2-
TAP WT and pCSR2-CSR2(S/T-A)-TAP plasmids were obtained by 
digestion of pSL308 and pSL351, respectively, with the restriction 
enzyme XhoI and by cotransformation and homologous recombina-
tion in yeast using a PCR product amplified from strain ySL1741 (in 
which Csr2 is endogenously tagged with a TAP cassette) using primers 
oSL806/oSL807, so that the C-terminal 3HA tag is replaced by the 
TAP cassette. Clones were rescued in bacteria and named pSL386 
(pCSR2-CSR2-TAP) and pSL387 (pCSR2-CSR2(S/T-A)-TAP).
The sequences of the primers used in this study are 
provided in Table S4.
Total protein extracts
Trichloroacetic acid (TCA; Sigma-Aldrich) was added directly to the 
culture to a final concentration of 10% (vol/vol) and incubated on ice 
for 10 min. Cells were then harvested by centrifugation for 1 min at 
room temperature at 16,000 g, then lysed with glass beads in 100 µl of 
TCA (10% vol/vol) for 10 min at 4°C. Beads were removed, the lysate 
was centrifuged for 1 min at room temperature at 16,000 g, and the 
resulting pellet was resuspended in a modified sample buffer (50 mM 
Tris-HCl, pH 6.8, 100 mM DTT, 2% SDS, 0.1% bromophenol blue, 
and 10% glycerol, containing an additional 200 mM of unbuffered Tris 
solution) at a concentration of 50 µl/initial OD unit, before being dena-
tured at 37°C for 10 min; 10 µl was loaded on SDS-PAGE gels.
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MG-132, cycloheximide, and 1NM-PP1 treatment
For MG-132 treatment, cells (pdr5Δ background) were treated with 
10  µM MG-132 (Sigma-Aldrich) 30 min before glucose addition in 
the medium. For cycloheximide treatment, cells were treated with 
100 µg/ml of cycloheximide (Sigma-Aldrich) for the indicated times.
For 1NM-PP1 treatment of the pkaas mutant strain (tpk1M164G 
tpk2M147G tpk3M165G) and its WT control (strains Y3561 and Y2864, 
respectively, provided by J.  Broach, Penn State University, Hershey, 
PA; Zaman et al., 2009), cells were harvested and transferred into 
SC medium containing 0.5% lactate and treated for 4  h with either 
50 µm 1NM-PP1 (1-[1,1-dimethylethyl]-3-[1-naphthalenylmeth-
yl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine; Cayman Chemical) or an 
equivalent volume of DMSO.
Antibodies, immunoblotting, quantifications, and statistical analysis
We used mouse monoclonal antibodies against GFP (clones 7.1 and 
13.1; 11814460001; Roche), HA (clone F7; sc-7392; Santa Cruz 
Biotechnology, Inc.), anti-ubiquitin coupled to horseradish peroxi-
dase (clone P4D1; sc-8017; Santa Cruz Biotechnology, Inc.) and rab-
bit polyclonal antibodies against 3-phosphoglycerate kinase (PGK; 
NE130/7S; Nordic-MUbio), Nedd4 (ab14592; Abcam), Bmh2 (a gift 
from S. Lemmon, University of Miami, Coral Gables, FL; Gelperin et 
al., 1995). Luminescence signals were acquired with the LAS-4000 im-
aging system (Fujifilm). Quantifications were performed using ImageJ 
(National Institutes of Health) on nonsaturated blots from independent 
experiments (n ≥ 3). The ratio of the free GFP signal over the total 
GFP signal in any given lane was calculated. A two-sided t test was 
performed and the p-values are indicated (NS, P > 0.05; *, P < 0.05; 
**, P < 0.01; ***, P < 0.001).
Fluorescence microscopy
Cells were mounted in the appropriate culture medium and imaged at 
room temperature with a motorized BX-61 fluorescence microscope 
(Olympus) equipped with a PlanApo 100× oil-immersion objective 
(1.40 NA; Olympus), a QiClick cooled monochrome camera (QImag-
ing), and the MetaVue acquisition software (Molecular Devices). GFP-
tagged proteins were visualized using a GFP filter set (41020; Chroma 
Technology Corp.; excitation HQ480/20×, dichroic Q505LP, emission 
HQ535/50m). For FM4-64 labeling, FM4-64 (Invitrogen) was added 
to 1 ml culture (10 µM final) and incubated at 30°C in a thermomixer 
for 15 min. Cells were then washed once with 1  ml medium. FM4-
64 signal was visualized using an HcRedI filter set (41043; Chroma 
Technology Corp.; excitation HQ575/50×, dichroic Q610lp, emission 
HQ640/50m). For CMAC (7-amino-4-chloromethylcoumarin) label-
ing, cells were incubated with 100  µM CMAC (Thermo Fisher Sci-
entific) for 10 min under agitation at 30°C, then washed twice with 
1 ml of medium. CMAC signal was visualized using a DAPI filter set 
(31013v2; Chroma Technology Corp.; excitation D365/10×, dichroic 
400dclp, emission D460/50m). Images were processed in ImageJ for 
levels and for contrast when indicated.
BiFC
Hxt6 was tagged with VC at its chromosomal locus, as previously 
described, using pFA6a-VC-kanMX6 (Sung and Huh, 2007). Csr2 was 
tagged with VN at its chromosomal locus, as previously described, 
using pFA6a-VN-His3MX6 (Sung and Huh, 2007; giving ySL1787), 
but no BiFC signal was observed, because of the low expression 
level of Csr2. Thus, plasmids expressing pTEF-driven Csr2-VN and 
derivatives were constructed as follows. Csr2-VN was PCR-amplified 
from genomic DNA prepared from strain ySL1787 using oSL1007/
oSL1008, digested XbaI–XhoI, and cloned XbaI–XhoI in pRS415-TEF 
(Mumberg et al., 1995), giving pSL391 (pTEF :Csr2 -VN). Csr2-KR-VN 
was constructed by cloning of a SalI–NheI fragment (containing the 
KR mutation) originating from pSL314 (see Plasmids and constructs 
section) into pSL391, giving pSL393 (pTEF :Csr2 -KR -VN). For the 
negative control, VN was PCR-amplified from pFA6a-VN-His3MX6 
and cloned at BamHI–EcoRV sites in pRS415 (giving pSL394). The 
pTEF promoter was excised from pRS415-TEF with SacI–BamHI 
and cloned at SacI–BamHI sites into pSL394, giving pSL392 
(pTEF:-Ø-VN). BiFC signals were visualized using a GFP filter set 
(41020 from Chroma Technology Corp.; excitation HQ480/20×, 
dichroic Q505LP, emission HQ535/50m).
Two-photon confocal microscopy
Two-photon confocal microscopy (Fig. 2) was performed according to 
Váchová et al. (2009). In brief, colonies were grown for 4 d at 28°C on 
glycerol-ethanol complete respiratory medium (1% yeast extract, 3% 
glycerol, 1% ethanol, 2% agar, and 10 mM CaCl2) medium, embedded 
in low-gelling agarose directly on the plates, and then cut vertically 
down the middle. They were placed on the coverslip (the cutting edge 
to the glass), and the colony side views of GFP fluorescence were 
obtained by two-photon confocal microscopy. Images were acquired 
with a true confocal scanner microscope (SP8 AOBS WLL MP; Leica 
Biosystems) fitted with a mode-locked laser (Ti :Sapphire Chameleon 
Ultra I; Coherent) for two-photon excitation and using 20×/0.70 and 
63×/1.20 water immersion plan apochromat objectives. Excitation 
wavelengths of 920 nm were used, with emission bandwidths set to 
480–595 nm. Images of whole colonies and central parts of the colonies 
were composed of two stitched fields of view.
β-galactosidase assays
For β-galactosidase assays, cells carrying pCSR2-lacZ plasmid (pSL168) 
were grown overnight in SC-based glucose medium to exponential 
phase. The A600 of each culture was measured and, for each assay, 1 ml 
of cells were harvested by centrifugation. The remaining cells were 
resuspended in SC-based lactate medium and grown for 2  h before 
the next assay. For each assay, cell pellets were frozen in liquid ni-
trogen and resuspended in 800 µl buffer Z (50 mM NaH2PO4, 45 mM 
Na2HPO4, 10 mM KCl, and 10 mM MgSO4, pH 7) to which β-mer-
captoethanol was added (27 µl/10 ml; Sigma-Aldrich). Then, 160 µl 
ortho-nitrophenyl-β-galactoside at 4 mg/ml (Sigma-Aldrich) were 
added, and samples were incubated at 37°C for 30 min, which was 
still in the linear phase of the reaction. The reactions were stopped by 
adding 400  µl 1  M Na2CO3. The samples were then centrifuged for 
2 min at 14,000 rpm to remove cell debris, and absorbance at 420 
nm (A420) was measured. To remove background in each experiment, 
assays were performed similarly using cells that did not express the 
lacZ reporter gene. β-Galactosidase activities were calculated as 
1,000 × [A420/(A600 × time)], where A420 is the mean of three technical 
replicates. For each experiment, histograms show the result and stan-
dard error of at least three independent biological replicates.
Quantitative RT-PCR
For quantitative RT-PCR, cells were grown overnight in glucose- 
containing SC medium and then switched into SC-lactate medium for 
2 h. For each sample, total RNA extractions were performed from 10 
OD units of cells, using the Nucleospin RNA II extraction kit (MAC 
HER EY-NAG EL). Reverse transcription reactions were performed 
using random hexamer primers (GE Healthcare; final concentration 
0.25 µg/µl) and Invitrogen SuperScript II reverse transcription. cDNA 
quantification was achieved through quantitative RT-PCR using a 
LightCycler 480 (Roche) according to the manufacturer’s instruc-
tions. CSR2 cDNAs were amplified using oSL685/oSL686 prim-
ers, and data were normalized to ACT1 transcripts (oligonucleotides 
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oSL704/oSL705). The sequences of the primers used in this study 
are provided in Table S4.
Purification of His6-tagged ubiquitylated conjugates
The purification of all cellular ubiquitylated conjugates for the ubiq-
uitylome experiments were performed from WT BY4741 cells trans-
formed with a plasmid encoding a pCUP1-driven His6-tagged ubiquitin 
(Gwizdek et al., 2006), provided by C. Dargemont (Hôpital St. Louis 
- Institut Universitaire d’Hématologie, Paris, France). These purifica-
tions were performed four times from four independent cultures. Cells 
were grown overnight in SC-based lactate medium to exponential phase 
(A600 = 0.3) without the addition of exogenous copper in the medium, 
to avoid His6-tagged ubiquitin overexpression. In each replicate, 50 
OD units of cells were harvested, and glucose (2% final) was added to 
the remaining cells. The remaining 50 OD units of cells were harvested 
after 10 min of glucose treatment. Several proteins, such as transcription 
factors or metabolic enzymes, are rapidly ubiquitylated and degraded 
by the proteasome in response to glucose (Spielewoy et al., 2004; 
Gancedo, 2008; Santt et al., 2008). To identify proteins that display 
other, nondegradative types of ubiquitylation, such as monoubiquityla-
tion or K63-linked ubiquitylation, we chose not to inhibit proteasomal 
degradation, which would favor the identification of K48-linked ubiq-
uitin chains (Xu et al., 2009). Thus, glucose treatment was performed 
without MG-132. The purification of His6-tagged ubiquitin conjugates 
was then performed using immobilized metal affinity chromatography 
as described later, following a protocol adapted from Ziv et al. (2011) 
and modified by Becuwe et al. (2012b). Cells were precipitated with 
TCA (10% final concentration) for 30 min on ice and lysed with glass 
beads for 20 min at 4°C.  After centrifugation, the pellet was resus-
pended with 500 µl guanidinium buffer (6 M GuHCl, 20 mM Tris-HCl, 
pH 8, 100 mM K2HPO4, 10 mM imidazole, 100 mM NaCl, and 0.1% 
Triton X-100) and incubated for 1 h at room temperature on a rotating 
platform. After centrifugation (16,000 g, 10 min at room temperature), 
the lysate was incubated for 2.5 h with nickel-nitriloacetic acid beads 
(Ni-NTA Superflow; QIA GEN). The beads were then washed three 
times with guanidinium buffer, three times with wash buffer 1 (20 mM 
Tris-HCl, pH 8.0, 100 mM K2HPO4, 20 mM imidazole, 100 mM NaCl, 
and 0.1% Triton X-100), and three times with wash buffer 2 (20 mM 
Tris-HCl, pH 8.0, 100 mM K2HPO4, 10 mM imidazole, 1 M NaCl, and 
0.1% Triton X-100). His6-ubiquitin-conjugated proteins were finally 
eluted with 40 µl elution buffer (50 mM Tris-HCl, pH 8.0, and 250 mM 
imidazole) for 10 min at room temperature.
For the purification of ubiquitylated species of Hxt6, vrp1Δ and 
vrp1Δcsr2-1 cells expressing endogenously tagged Hxt6-GFP were 
transformed with the pCUP1-driven His6-tagged ubiquitin construct 
described in the preceding paragraph. Cells were grown overnight in 
SC-based glucose medium to exponential phase (A600 = 0.3), resus-
pended in SC-based lactate medium to which 100  µM CuSO4 was 
added, and grown for 6  h at 30°C.  Cell pellets (50 OD units) were 
frozen at −80°C.  Cells were then precipitated with TCA (10% final 
concentration) for 30 min on ice and lysed with glass beads for 10 
min at 4°C. Cell lysates were centrifuged for 1 min at room tempera-
ture at 16,000 g, and the resulting pellet was resuspended in a modi-
fied sample buffer (50 mM Tris-HCl, pH 6.8, 100 mM DTT, 2% SDS, 
0.1% bromophenol blue, and 10% glycerol, containing an additional 
200 mM of unbuffered Tris solution) at a concentration of 10 initial 
OD units/50 µl. Samples were then diluted 20 times in guanidinium 
buffer (6 M GuHCl, 20 mM Tris-HCl, pH 8, 100 mM K2HPO4, 10 mM 
imidazole, 100 mM NaCl, and 0.1% Triton X-100) and incubated for 
2 h with nickel-nitriloacetic acid beads (Ni-NTA Superflow) at room 
temperature on a rotating platform. The beads were then washed three 
times with guanidinium buffer, three times with wash buffer 1 (20 mM 
Tris-HCl, pH 8.0, 100 mM K2HPO4, 20 mM imidazole, 100 mM NaCl, 
and 0.1% Triton X-100), and three times with wash buffer 2 (20 mM 
Tris-HCl, pH 8.0, 100  mM K2HPO4, 10  mM imidazole, 1  M NaCl, 
and 0.1% Triton X-100). His6-ubiquitin-conjugated proteins were fi-
nally eluted with 100 µl elution buffer (50 mM Tris-HCl, pH 8.0, and 
250 mM imidazole) for 10 min at room temperature.
Liquid chromatography–tandem mass spectrometry acquisition
Proteins were digested overnight at 37°C in 20 µl 25 mM NH4HCO3 
containing sequencing-grade trypsin (12.5 µg/ml; Promega). The re-
sulting peptides were sequentially extracted with 70% acetonitrile and 
0.1% formic acid. Digested samples were acidified with 0.1% formic 
acid. All digests were analyzed by a LTQ Velos Orbitrap (Thermo 
Fisher Scientific) equipped with an EASY-Spray nanoelectrospray ion 
source (Thermo Fisher Scientific) coupled to an Easy nano-LC Proxeon 
1000 system (Thermo Fisher Scientific). Chromatographic separation 
of peptides was performed with the following parameters: Acclaim 
PepMap100 C18 precolumn (2 cm, 75 µm inside diameter, 3 µm, 100 
Å), Pepmap-RSLC Proxeon C18 column (50 cm, 75 µm inside diam-
eter, 2 µm, 100 Å), 300 nl/min flow, using a gradient rising from 95% 
solvent A (water, 0.1% formic acid) to 35% B (100% acetonitrile, 0.1% 
formic acid) in 107 min, followed by a column regeneration of 13 min, 
for a total run of 2 h. Peptides were analyzed in the Orbitrap in full-
ion scan mode at a resolution of 30,000 (at m/z 400) and with a mass 
range of m/z 400–1,800. Fragments were obtained with a collision- 
induced dissociation activation with a collisional energy of 40%, an 
isolation width of 2 D, and an activation Q of 0.250 for 10 ms. Tandem 
mass spectrometry data were acquired in the linear ion trap in a data- 
dependent mode, in which the 20 most intense precursor ions were 
fragmented, with a dynamic exclusion of 20 s, an exclusion list size of 
500, and a repeat duration of 30 s.
Raw mass spectrometry data from the LTQ Velos Orbitrap were 
analyzed with MaxQuant (Cox and Mann, 2008) version 1.5.2.8, using 
the Andromeda peptide search engine (Cox et al., 2011). Quantifica-
tions were performed with MaxLFQ (Cox et al., 2014) using the pro-
teins identified with at least two peptides and analyzed with Perseus 
software version 1.5.0.15. For the statistical analysis of ubiquitylome 
experiments, four replicates of each condition (glucose and lactate) 
were separated into two statistical groups, and a Student’s t test was 
performed on both groups with a randomization number of 250 to 
determine the protein enrichments between the groups. The results 
are displayed as a volcano plot (Hubner and Mann, 2011); the black 
curves were plotted using a false discovery rate of 0.05 and S0 = 0.2 
to highlight the candidates that were significantly enriched in each 
condition, respectively.
Csr2-3HA purification for the mapping of phosphorylation and 
ubiquitylation sites by mass spectrometry
Cells expressing an HA-tagged version of Csr2 (endogenously tagged 
at its genomic locus; ySL1037) were grown overnight at 30°C in 
glucose-containing SC medium to an A600 of 0.3–0.6 and transferred to 
SC-lactate medium for 4 h at 30°C. Cells from half of the culture (∼400 
OD units) were collected by centrifugation (5 min, 4,000 g, 4°C). Glu-
cose (2% final) was added to the other half, and cells were incubated 
for 5 min at 30°C before being harvested. Each pellet was resuspended 
in 4 ml lysis buffer (200 mM Tris-HCl, pH 8.0, 200 mM NaCl, 1 mM 
EDTA, 5% glycerol, 0.5 mM DTT, and 0.1% Triton X-100) contain-
ing protease inhibitors (1 mM phenylmethylsulfonyl fluoride [Sigma- 
Aldrich], 10 mM N-ethylmaleimide [Sigma-Aldrich], 100 µM MG-132 
[Enzo Life Sciences], and 1% yeast protease inhibitor cocktail [P8215; 
Sigma-Aldrich]). Cells were mechanically disrupted with glass beads 
on a vortex at 4°C for 4 × 30 s. The lysate was then cleared at 3,000 g 
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for 5 min, at 4°C, and the supernatant was incubated with 25 µl anti-HA 
affinity resin (Roche) for 1 h 30 min at 4°C under rotation. The beads 
were then washed three times with lysis buffer and once with H2O and 
resuspended in 100 µl H2O, before being subjected to trypsin digestion 
and mass spectrometry analysis.
Protein A–tagged protein pulldowns
Cells transformed with plasmids carrying C-terminal TAP fusions of 
Csr2 (Rigaut et al., 1999) or with pRS315 as a negative control were 
grown overnight in 4 liters synthetic glucose medium without leucine 
until A600 = 0.6. The cultures were centrifuged and then switched to 
synthetic lactate medium without leucine for 4 h. Cultures were then 
separated into two aliquots: one was directly centrifuged and kept at 
4°C, while the other was incubated with 2% glucose for 4 min before 
centrifugation. Cell pellets were rinsed with cold MilliQ water, re-
suspended in lysis buffer (200 mM Tris-HCl, pH 8.0, 100 mM NaCl, 
1 mM EDTA, 5% glycerol, 10 mM PMSF, 10 mM N-ethylmaleimide, 
10 µM MG-132, and a tablet of cOmplete protease inhibitor cocktail; 
Roche) and lysed with glass beads (4 × 1 min at 4°C). Lysates were 
cleared by centrifugation, 50 µl inputs were isolated, and the cleared 
lysates were incubated with 50 µl IgG-coupled magnetic beads (Dy-
nabeads; Thermo Fisher Scientific) for 45 min at 4°C (Oeffinger et al., 
2007). Beads were collected with a magnetic rack and washed four 
times in 1 ml lysis buffer containing 0.1% Triton X-100. Proteins asso-
ciated with the IgG-coupled magnetic beads were eluted in 400 µl lysis 
buffer containing 1% Empigen BB detergent (Sigma-Aldrich) for 2 h 
at 4°C. Beads were discarded with a magnet, and eluted proteins were 
precipitated using the methanol-chloroform method and resuspended in 
15 µl sample buffer. In parallel, inputs were precipitated with 10% TCA 
and resuspended in 50  µl sample buffer. All samples were heated at 
95°C for 5 min, loaded on a NuPAGE 4–12% gradient polyacrylamide 
gel, and blotted on a nitrocellulose membrane for Western blot analysis.
Online supplemental material
Tables listing yeast strains, plasmids, and primers used in this study 
are provided as supplemental tables (Tables S1 and S2, S3 and S4, re-
spectively). Supplemental figures also accompany this paper. Fig. S1 
shows the rationale behind the genesis of the csr2-1 mutant. Fig. S2 
presents the regulation of various hexose transporters, including Hxt5. 
Fig. S3 shows that Csr2-3HA is a short-lived protein. Fig. S4 relates 
to the identification of the ubiquitylation site on Csr2, and displays the 
blot quantified in Fig. 8 D. Fig. S5 displays controls for the study of 
the N-terminal region of Csr2, results obtained while screening kinase 
mutants impacting on Csr2 regulation, and controls for Fig. 10.
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(LQ1604 NPU II) to Z. Palková and the Czech Science Foundation (15-
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Figure S1. Requirement of Csr2 for Hxt6 endocytosis after glucose removal, and rationale for the construction of the csr2-1 mutant. (A) Hxt6-GFP endocy-
tosis in lactate-containing medium requires Csr2, but not its close paralogue Ecm21. Hxt6-GFP-expressing WT (ySL1184), csr2Δ (ySL1185), and ecm21Δ 
(ySL1650) cells were grown overnight in glucose medium (exponential phase) and were switched to lactate-containing medium. Cells were imaged for 
Hxt6 localization at the indicated times. Hxt6-GFP endocytosis occurs in an ecm21Δ mutant but not in csr2Δ cells. Note that Hxt6-GFP is expressed at a 
lower level in the csr2Δ strain as compared with WT cells. (B) From the experiment depicted in A, immunoblots were realized on total cell lysates with the 
indicated antibodies (PGK was used as a loading control). Note that Hxt6-GFP is expressed at a lower level in the csr2Δ strain compared with WT cells. 
(C) Hxt7-GFP is also expressed at a much lower level in the csr2Δ strain compared with WT cells. WT and csr2Δ cells expressing Hxt6-GFP (ySL1184 and 
ySL1185), Hxt7-GFP (ySL1551 and ySL1552), Hxt2-GFP (ySL1140 and ySL1654), or Hxt5-GFP (ySL1145 and ySL1653) were grown overnight in glucose 
medium (exponential phase) and switched to lactate-containing medium for 2 h. Total cell lysates were prepared at the indicated times and immunoblotted 
with anti-GFP and anti-PGK (loading control) antibodies. (D) The defect in Hxt6-GFP expression observed in the csr2Δ mutant is not complemented by a 
plasmid containing the CSR2 gene. Hxt6-GFP-expressing WT (ySL1345), csr2Δ (ySL1316), or csr2Δ cells carrying a plasmid-encoded, unmodified CSR2 
gene (−500/+300; ySL1670) were grown overnight in glucose medium (exponential phase) and switched to lactate-containing medium for 2 h. Total 
cell lysates were immunoblotted with anti-GFP and anti-PGK (loading control) antibodies. (E) Schematic of the genomic locus around CSR2. The regions 
covered by two genomic clones, YGPM19n08 and YGPM32j02 (from the yeast genomic tiling collection; GE Healthcare) are represented in green and 
blue, respectively. (F) The defective expression of Hxt6-GFP observed in the csr2Δ mutant is not complemented by the genomic clones tested. Hxt6-GFP-ex-
pressing WT (ySL1345), csr2Δ (ySL1316), or csr2Δ cells carrying genomic clones indicated in E (YGPM32j02 or YGPM19n08: ySL1692 and ySL1693) 
were grown overnight in glucose medium (exponential phase) and switched to lactate-containing medium for 2 h. Total cell lysates were immunoblotted 
with anti-GFP and anti-PGK (loading control) antibodies. (G) Schematic of the strategy used to generate the csr2-1 allele. A cassette containing a KanMx 
cassette, LoxP excision sites, and a stop codon in its 5′ was integrated 45 bp away from the start site of CSR2. Note that the cassette was not excised 
and thus is still present in the csr2-1 mutant. (H) Hxt6-GFP expression is not altered in the csr2-1 mutant. WT (ySL1184), csr2Δ (ySL1185), and csr2-1 
(ySL1706) cells expressing Hxt6-GFP were grown overnight in glucose medium (exponential phase) and were switched to lactate-containing medium for 
2 h. Total cell lysates were prepared at this time and immunoblotted with anti-GFP and anti-PGK (loading control) antibodies. (I) Csr2 is not expressed 
in the disrupted mutant csr2-1. A 3HA-tagging cassette was introduced in 3′ of the CSR2 ORF, in both the WT and the csr2-1 genomic context. In both 
cases, the correct and in-frame insertion of the cassette with the CSR2 ORF was verified by PCR and sequencing. The indicated strains (csr2-1: ySL1706; 
csr2-1-3HA: ySL1717; Csr2-3HA: ySL1037) were grown in lactate medium for 4 h, and total cell lysates were immunoblotted with anti-HA and anti-PGK 
(loading control) antibodies.
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Figure S2. Cargo selectivity of the ART Csr2 during endocytosis in the absence of glucose. (A) Comparison of the expression and localization of seven 
hexose transporters (Hxt1 to Hxt7) fused to GFP. Cells were grown overnight in glucose medium (exponential phase) and then switched to lactate-containing 
medium and imaged at the indicated times. All hexose transporter genes were tagged at the chromosomal locus by homologous recombination, and their 
expression was driven by their endogenous promoter (Hxt1-GFP: ySL1186; Hxt2-GFP: ySL1140; Hxt3-GFP: ySL1027; Hxt4-GFP: ySL1852; Hxt5-GFP: 
ySL1145; Hxt6-GFP: ySL1184; Hxt7-GFP: ySL1551). (B) WT (ySL1145) and csr2-1 cells (ySL2065) expressing Hxt5-GFP were grown overnight in glucose 
medium and switched to lactate medium for the indicated time and images by fluorescence microscopy. (C) From the experiment presented in B, immu-
noblots were realized from total cell lysates using anti-GFP and anti-PGK antibodies. (D) GFP signals were quantified (± SEM) at 7- and 24-h time points 
(n = 3 independent experiments).
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Figure S3. Csr2-3HA is a short-lived protein. (A) WT cells expressing Csr2-3HA (pdr5Δ background; ySL1826) were grown in glucose medium and were 
switched to lactate-containing medium for 2 h to induce Csr2-3HA synthesis (lane 1). They were then treated with cycloheximide (CHX) for various times 
(up to 1 h, lanes 3–6). As a control, no cycloheximide was added for 1 h (lane 2). Another batch of cells were treated with glucose for various times (up to 
1 h, lanes 7–10) to repress Csr2-3HA expression. A similar experiment was performed in the presence of the proteasome inhibitor, MG-132 (lanes 11–14). 
(B) The blot displayed in A (nonsaturated blot acquired using a LAS-4000 imaging system) was used for quantification of band intensities and normalized 
to the initial Csr2-3HA signal (lane 1). The distribution of normalized abundance over time is shown, as well as exponential fits and its parameters, and 
the calculated half-life (t1/2). (C) WT cells expressing either Csr2-3HA (ySL1037, top) or Csr2-TAP (ySL1741, bottom) were grown in glucose medium and 
were switched to lactate-containing medium for 2 h. They were then treated with glucose for the indicated times. Total cell lysates were prepared at the 
indicated times and immunoblotted with anti-HA (top) or anti-peroxidase antibodies (PAP, bottom) and anti-PGK antibodies. Note that even though Csr2-
TAP ubiquitylation vanishes at t = 10 min glucose treatment, it reappears at later time points, suggesting that the loss of Csr2 ubiquitylation is part of an 
early glucose response.
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Figure S4. Identification of the ubiquitylation site on Csr2. (A) An immunoprecipitation was performed using lactate-grown Csr2-3HA cells (ySL1037) as 
starting material (see Materials and methods). The tandem mass spectrometry spectrum showing the intensities of the fragmented ions provides evidence of 
a diglycine remnant owing to Csr2 ubiquitylation at Lys670. Other features of this peptide are provided. FDR, false discovery rate. (B) From the experiment 
presented in Fig. 8 C, immunoblots were done on total cell lysates using anti-GFP and anti-PGK antibodies.
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Figure S5. Study of the N-terminal region of Csr2. (A) csr2-1 cells expressing Hxt6-GFP transformed with an empty plasmid (ySL1876) or a plasmid 
encoding either a full-length Csr2-3HA (ySL1714) or devoid of its first 150 residues in N-terminal (ySL1828) were grown in glucose medium and were 
switched to lactate-containing medium. They were imaged for Hxt6-GFP localization at the indicated times. (B) Glucose-grown WT cells expressing a 
truncated Csr2-3HA construct (Δ150), in which the conserved K670 residue is mutated or not (ySL1830 or ySL1818, respectively) were switched to lactate- 
containing medium for 4 h and then treated with glucose for 10 min. Total cell lysates were prepared at the indicated times and immunoblotted with anti-HA 
antibody. A scan of the Ponceau stain is provided as a loading control. (C) Glucose-grown csr2-1 cells expressing Hxt6-GFP and either no Csr2, Csr2-3HA, 
or Csr2(S/T-A) (ySL1721, ySL1714, and ySL1849, respectively) were grown in glucose medium, switched to lactate-containing medium, and imaged at 
the indicated times. (D) From the experiment presented in C total cell lysates were prepared at the indicated times and immunoblotted using anti-GFP and 
anti-PGK antibodies. (E) Screening of kinase mutants potentially regulating Csr2 ubiquitylation. Mutant strains expressing a plasmid-encoded Csr2-TAP 
construct (see Table S2) were grown in glucose medium and switched to lactate-containing medium for 4 h. They were then treated with glucose for 10 min. 
Immunoblots were realized on total cell lysates using PAP and PGK (loading control) antibodies. (F) Evidence that the N-terminal region of Csr2 is required 
for the constitutive deubiquitylation of Csr2 observed in the bcy1Δ mutant: bcy1Δ cells expressing HA-tagged Csr2(Δ150) (ySL2070) or Csr2(Δ150,KR) 
(ySL2071) were grown in glucose medium and switched to lactate-containing medium for 4 h. They were then treated with glucose for 10 min. Immunoblots 
were realized on total cell lysates using anti-HA and anti-PGK (loading control) antibodies. (G) Evidence that PKA activity is induced during a lactate/
glucose shift: WT (ySL2087) or tpkas mutant cells(ySL2088) expressing Msn2 was grown overnight in glucose-containing medium (exponential phase), then 
switched to lactate-containing medium and treated with 50 µM 1-NMPP1 (or an equivalent volume of DMSO as a negative control) for 4 h. Glucose was 
added back (final concentration 2%), and cells were imaged at the indicated times.
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Table S1. List of yeast strains, per figure
Figure Yeast strains
Fig. 1 (A) ySL1184, ySL1551; (B) ySL1184; (C) ySL1184, ySL1643, ySL1539; (D) ySL1315, ySL1698, ySL1790, ySL1688; (E) ySL1184, 
ySL1706, ySL1551, ySL1718
Fig. 2 (A–D) ySL1184, ySL1706
Fig. 3 (A) ySL2027, ySL2028, ySL2023, ySL2025; (B) ySL2023; (C) ySL1643, ySL1809; (E) ySL1833, ySL1835
Fig. 4 (A) ySL1186, ySL1187, ySL1027, ySL1058; (C): ySL1140, ySL1654, ySL1852, ySL1853
Fig. 5 (A) ySL1037; (B): ySL1184, ySL1551; (C) ySL1188; (D) ySL1188, ySL1189 ySL1190; (E) ySL1188, ySL1779, ySL1816, ySL1780; 
(F) ySL1037, ySL1191, ySL1192; ySL1774
Fig. 6 (A) ySL1037, ySL1726; (B) ySL1184, ySL1734; (E) ySL1184; (F) ySL1953
Fig. 7 (A) ySL1212; (B) ySL1037, ySL1210; (C) ySL1655, ySL1680; (D) ySL820
Fig. 8 (B) ySL1655, ySL1677; (C) ySL1345, ySL1721, ySL1714, ySL1716; (E) ySL2023, ySL2026
Fig. 9 (A and B) ySL1037; (C) ySL1037, ySL1043; (D) ySL1043, ySL1896, ySL1897
Fig. 10 (B) ySL1826, ySL1827; (C) ySL1655, ySL1848; (D) ySL1655, ySL2021, ySL1848, ySL2043; (E) ySL2085, ySL2086; (F) ySL1876, 
ySL1877, ySL1881
For supplemental figures, please refer to their legends.
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Table S2. Description of the yeast strains used in this study
Name/description Genotype Origin/reference
ySL820 WT + pCUP1 :6xHis -Ubi Mat a, his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 (pSL206: pCUP1 :6xHis -Ubi, URA3) This study
ySL1027 Hxt3-GFP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, HXT3::GFP-HIS3MX6 GFP collection (Huh et al., 2003)
ySL1037 Csr2-3HA Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, CSR2-3HA::kanMX4 This study
ySL1043 ubp2Δ Csr2-3HA Mat α, his3Δ1, leu2Δ0, lysΔ0, ura3Δ0, ubp2Δ::HIS MX3; CSR2-3HA::kanMX This study
ySL1058 csr2Δ Hxt3-GFP Mat a, his3Δ,1 leu2Δ0, met15Δ0, ura3Δ0, csr2Δ::kanMX6, HXT3::GFP-HIS3MX6 This study
ySL1140 Hxt2-GFP Mat a, his3Δ,1 leu2Δ0, met15Δ0, ura3Δ0, HXT2::HIS3MX6 GFP collection (Huh et al., 2003)
ySL1145 Hxt5-GFP Mat a, his3Δ,1 leu2Δ0, met15Δ0, ura3Δ0, HXT5::GFP-HIS3MX6 GFP collection (Huh et al., 2003)
ySL1184 Hxt6-GFP Mat a, his3Δ,1 leu2Δ0, met15Δ0, ura3Δ0, HXT6::GFP-HIS3MX6 This study
ySL1185 csr2Δ Hxt6-GFP Mat a, his3Δ,1 leu2Δ0, met15Δ0, ura3Δ0, csr2Δ::kanMX, HXT6::GFP-HIS3MX6 This study
ySL1186 Hxt1-GFP Mat a, his3Δ,1 leu2Δ0, met15Δ0, ura3Δ0, HXT1::GFP-HIS3MX6 This study
ySL1187 csr2Δ Hxt1-GFP Mat a, his3Δ,1 leu2Δ0, met15Δ0, ura3Δ0, HXT1::GFP-HIS3MX6 csr2Δ::kanMX This study
ySL1188 WT + pCSR2-lacZ Mat a, his3Δ,1 leu2Δ0, met15Δ0, ura3Δ0 (pSL168, URA3) This study
ySL1189 snf1Δ + pCSR2-lacZ Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, snf1Δ::kanMX (pSL168, URA3) This study
ySL1190 reg1Δ + pCSR2-lacZ Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, reg1Δ::HIS3MX6 (pSL168, URA3) This study
ySL1191 snf1Δ Csr2-3HA Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, CSR2-3HA::kanMX, snf1Δ:: hphNT1 This study
ySL1192 reg1Δ Csr2-3HA Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, CSR2-3HA::kanMX, reg1Δ::HIS3MX6 This study
ySL1210 npi1 Csr2-3HA Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, pRSP5::HIS3MX6; CSR2-3HA::kanMX This study
ySL1212 Csr2-3HA + pCUP1 :6xHis -Ubi Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, CSR2-3HA::kanMX (pSL206, URA3) This study
ySL1315 Hxt6-GFP + pRS416 Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, HXT6::GFP-HIS3MX (pRHT95, URA3) This study
ySL1316 csr2Δ Hxt6-GFP + pRS416 Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, csr2Δ::kanMX, HXT6::GFP-HIS3MX 
(pRHT95, URA3)
This study
ySL1345 Hxt6-GFP + pRS315 Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, Hxt6::GFP-HIS3MX (pRHT91, LEU2) This study
ySL1539 npi1 Hxt6-GFP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, pRSP5::kanMX, HXT6::HIS3MX6 This study
ySL1551 Hxt7-GFP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, HXT7-GFP:: hphNT1 This study
ySL1552 csr2Δ Hxt7-GFP Mat a, his3Δ,1 leu2Δ0, met15Δ0, ura3Δ0, csr2Δ:: kanMX, HXT7-GFP:: hphNT1 This study
ySL1643 vrp1Δ Hxt6-GFP Mat α, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0, vrp1Δ::kanMX; HXT6-GFP:: HIS3MX6 This study
ySL1650 ecm21Δ Hxt6-GFP Mat a, his3Δ,1 leu2Δ0, met15Δ0, ura3Δ0, ecm21Δ::hphNT1, 
HXT6::GFP-HIS3MX6
This study
ySL1653 csr2Δ Hxt5-GFP Mat a, his3Δ,1 leu2Δ0, met15Δ0, ura3Δ0, csr2Δ::hphNT1, HXT5::GFP-HIS3MX6 This study
ySL1654 csr2Δ Hxt2-GFP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, HXT2::GFP-HIS3MX6, csr2Δ:: 
hphNT1
This study
ySL1655 WT + pCSR2-CSR2-3HA Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0 (pSL308, LEU2) This study
ySL1670 csr2Δ Hxt6-GFP + p416-pCSR2 Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, csr2Δ::kanMX, HXT6::GFP-HIS3MX 
(pSL316, URA3)
This study
ySL1677 WT + pCSR2-CSR2(KR)-3HA Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0 (pSL318, LEU2) This study
ySL1680 WT + pCSR2-CSR2(PYm)-3HA Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0 (pSL319, LEU2) This study
ySL1688 9arrestinΔ Hxt6-GFP + 
pRS416-CSR2
Mat a, ura3, leu2, art1Δ, ecm21Δ::kanMX, aly1Δ, rod1Δ, art5Δ, aly2Δ, 
rog3::natMX; csr2Δ::kanMX, art10Δ::HIS, bsd2Δ HXT6-GFP:: hphNT1 
(pSL316, URA3)
This study (9arrestinΔ: Nikko and 
Pelham, 2009)
ySL1692 csr2Δ Hxt6-GFP + YGPM32j02 Mat a, his3Δ,1 leu2Δ0, met15Δ0, ura3Δ0, csr2Δ::kanMX, HXT6::GFP-HIS3MX6 
+ YGPM32j02 (pSL315, LEU2)
This study
ySL1693 csr2Δ Hxt6-GFP + YGPM19n08 Mat a, his3Δ,1 leu2Δ0, met15Δ0, ura3Δ0, csr2Δ::kanMX, HXT6::GFP-HIS3MX6 
+ YGPM19n08 (pSL358, LEU2)
This study
ySL1698 9arrestinΔ Hxt6-GFP + pRS416 Mat a, ura3, leu2, art1Δ, ecm21Δ::kanMX, aly1Δ, rod1Δ, art5Δ, aly2Δ, 
rog3::natMX; csr2Δ::kanMX, art10Δ::HIS, bsd2Δ HXT6-GFP:: hphNT1 
(pRHT95, URA3)
This study
ySL1706 csr2-1 Hxt6-GFP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, csr2-1::kanMX, HXT6::GFP-HIS3MX This study
ySL1714 csr2-1 Hxt6-GFP + 
pCSR2-CSR2-3HA
Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, csr2-1::kanMX, HXT6::GFP-HIS3MX 
(pSL308, LEU2)
This study
ySL1716 csr2-1 Hxt6-GFP + 
pCSR2-CSR2-KR-3HA
Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, csr2-1::kanMX, HXT6::GFP-HIS3MX 
(pSL318, LEU2)
This study
ySL1717 csr2-1-3HA Hxt6-GFP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, csr2-1::kanMX, CSR2::3HA-hphNT1, 
HXT6::GFP-HIS3MX
This study
ySL1721 csr2-1 Hxt6-GFP + pRS315 Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, csr2-1::kanMX, HXT6::GFP-HIS3MX 
(pRHT91, LEU2)
This study
ySL1726 pTEF-CSR2-3HA Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, pCSR2 :: natNT2-pTEF, CSR2 :3HA 
::kanMX4
This study
ySL1734 Hxt6-GFP pTEF-CSR2 Hxt6-GFP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, pCSR2 :: natNT2-pTEF, 
HXT6::GFP-HIS3MX6
This study
ySL1741 Csr2-TAP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, CSR2-TAP::kanMX This study
ySL1774 mig1Δmig2Δ Csr2-3HA Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, mig1Δ:: hphNT1, mig2Δ::HIS3MX6, 
CSR2-3HA::kanMX4
This study
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Name/description Genotype Origin/reference
ySL1779 mig1Δ + pCSR2-lacZ Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, mig1Δ:: hphNT1 CSR2-3HA::kanMX4 
(pSL168, URA3)
This study
ySL1780 mig1Δmig2Δ + pCSR2-lacZ Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, mig1Δ:: hphNT1, mig2Δ::HIS3MX6, 
CSR2-3HA::kanMX4 (pSL168, URA3)
This study
ySL1790 9arrestinΔ Hxt6-GFP + pECM21 
:ECM21 -3HA
Mat a, ura3, leu2, art1Δ, ecm21Δ::kanMX, aly1Δ, rod1Δ, art5Δ, aly2Δ, 
rog3::natMX; csr2Δ::kanMX, art10Δ::HIS, bsd2Δ HXT6-GFP:: hphNT1 
(pSL324, LEU2)
This study
ySL1809 vrp1Δ csr2-1 Hxt6-GFP Mat a, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0, vrp1Δ::kanMX; HXT6-GFP:: HIS3MX6 
csr2-1::kanMX
This study
ySL1810 mig1Δ mig2Δ Hxt6-GFP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, mig1Δ::hphNT1; mig2Δ::KanMX; 
HXT6::GFP-HIS3MX6
This study
ySL1811 mig1Δ mig2Δ csr2-1 Hxt6-GFP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, mig1Δ::hphNT1; mig2Δ::KanMX; 
csr2-1::NAT; HXT6::GFP-HIS3MX6
This study
ySL1816 mig2Δ + pCSR2-lacZ Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, mig2Δ::HIS3MX6, 
CSR2-3HA::kanMX4
This study
ySL1818 WT + pCSR2-CSR2(Δ150)-3HA Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0 (pSL325, LEU2) This study
ySL1826 pdr5Δ + pCSR2-CSR2-3HA Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, pdr5Δ::HIS3MX6 (pSL325, LEU2) This study
ySL1827 pdr5Δ + pCSR2-CSR2(Δ150)-3HA Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, pdr5Δ::HIS3MX6 (pSL308, LEU2) This study
ySL1828 Hxt6-GFP csr2-1 + 
pCSR2-CSR2(Δ150)-3HA
Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, csr2-1::kanMX, HXT6::GFP-HIS3MX6, 
(pSL325, LEU2)
This study
ySL1830 WT + pCSR2-CSR2(Δ150,KR)-3HA Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0 (pSL345, LEU2) This study
ySL1833 vrp1Δ Hxt6-GFP + pCUP1 :6xHis 
-Ubi
vrp1Δ::kanMX; HXT6::GFP-HIS3MX6, Matα, lys-, met? (pSL206: pCUP1 :6xHis -Ubi, 
URA3)
This study
ySL1835 vrp1Δ csr2-1 Hxt6-GFP + pCUP1 
:6xHis -Ubi
Mat a, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0, vrp1Δ::kanMX, csr2-1::kanMX, 
HXT6::GFP-HIS3MX6 (pSL206, URA3)
This study
ySL1848 WT + pCSR2 :CSR2(S /T -A) -3HA Mat a, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0 (pSL351, LEU2) This study
ySL1849 csr2-1 Hxt6-GFP + pCSR2-CSR2(S/
T-A)-3HA
Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, csr2-1::kanMX, HXT6::GFP-HIS3MX 
(pSL351, LEU2)
This study
ySL1852 Hxt4-GFP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, HXT4::GFP-HIS3MX6 This study
ySL1853 csr2-1 Hxt4-GFP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, HXT4::GFP-HIS3MX6, csr2-1::kanMX This study
ySL1876 csr2-1 Hxt6-GFP + pRS315 Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, csr2-1::kanMX, HXT6::GFP-HIS3MX 
(pRHT91, LEU2)
This study
ySL1877 csr2-1 Hxt6-GFP + pCSR2 :CSR2 
-TAP
Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, csr2-1::kanMX, HXT6::GFP-HIS3MX 
(pSL386, LEU2)
This study
ySL1881 csr2-1 Hxt6-GFP + pCSR2 :CSR2(S 
/T -A) -TAP
Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, csr2-1::kanMX, HXT6::GFP-HIS3MX 
(pCSR2-CSR2(S/T-A)-TAP, CEN, LEU2)
This study
ySL1896 ubp2Δ Csr2-3HA + pCUP1 :Ub -WT Mat α, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0, ubp2Δ::HIS MX3, CSR2-3HA::kanMX 
(pRHT86, LYS2)
This study
ySL1897 ubp2Δ Csr2-3HA + pCUP1 :Ub 
-K63R
Mat α, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0, ubp2Δ::HIS MX3, CSR2-3HA::kanMX 
(pRHT88, LYS2)
This study
ySL1953 Hxt6-GFP + pCSR2 :CSR2 -3HA Mat a, his3Δ,1 leu2Δ0, met15Δ0, ura3Δ0, HXT6::GFP-HIS3MX6 This study
ySL1982 gin4Δ + pCSR2 :CSR2 -TAP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, gin4Δ::KanMX (pSL386, LEU2) 
[gin4Δ/ySL1957 = deletion collection, checked by PCR]
This study
ySL1983 ypk2Δ + pCSR2 :CSR2 -TAP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, ypk2Δ::KanMX (pSL386, LEU2) 
[ypk2Δ/ySL1958 = deletion collection, checked by PCR]
This study
ySL1985 yak1Δ + pCSR2 :CSR2 -TAP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, yak1Δ::KanMX (pSL386, LEU2) 
[yak1Δ/ySL1960 = deletion collection, checked by PCR]
This study
ySL1986 slt2Δ + pCSR2 :CSR2 -TAP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, slt2Δ::KanMX (pSL386, LEU2) 
[slt2Δ/ySL1961 = deletion collection, checked by PCR]
This study
ySL1987 ark1Δ + pCSR2 :CSR2 -TAP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, ark1Δ::KanMX (pSL386, LEU2) 
[ark1Δ/ySL1962 = deletion collection, checked by PCR]
This study
ySL1988 akl1Δ + pCSR2 :CSR2 -TAP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, akl1Δ::KanMX (pSL386, LEU2) 
[akl1Δ/ySL1963 = deletion collection, checked by PCR]
This study
ySL1989 fpk1Δ + pCSR2 :CSR2 -TAP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, fpk1Δ::KanMX (pSL386, LEU2) 
[fpk1Δ/ySL1964 = deletion collection, checked by PCR]
This study
ySL1990 prk1Δ + pCSR2 :CSR2 -TAP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, prk1Δ::KanMX (pSL386, LEU2) 
[prk1Δ/ySL1965 = deletion collection, checked by PCR]
This study
ySL1991 fmp48Δ + pCSR2 :CSR2 -TAP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, fmp48Δ::KanMX (pSL386, LEU2) 
[fmp48Δ/ySL1966 = deletion collection, checked by PCR]
This study
ySL1992 cmk1Δ + pCSR2 :CSR2 -TAP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, cmk1Δ::KanMX (pSL386, LEU2) 
[cmk1Δ/ySL1967 = deletion collection, checked by PCR]
This study
ySL1993 yck3Δ + pCSR2 :CSR2 -TAP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, yck3Δ::KanMX (pSL386, LEU2) 
[yck3Δ/ySL1968 = deletion collection, checked by PCR]
This study
ySL1994 vhs1Δ + pCSR2 :CSR2 -TAP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, vhs1Δ::KanMX (pSL386, LEU2) 
[vhs1Δ/ySL1969 = deletion collection, checked by PCR]
This study
Table S2. Description of the yeast strains used in this study (Continued)
Mechanism of endocytosis during glucose depletion • Hovsepian et al. S31
Name/description Genotype Origin/reference
ySL1995 sch9Δ + pCSR2 :CSR2 -TAP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, sch9Δ::KanMX (pSL386, LEU2) 
[sch9Δ/ySL1970 = deletion collection, checked by PCR]
This study
ySL1996 psk2Δ + pCSR2 :CSR2 -TAP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, psk2Δ::KanMX (pSL386, LEU2) 
[psk2Δ/ySL1971 = deletion collection, checked by PCR]
This study
ySL1997 mek1Δ + pCSR2 :CSR2 -TAP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, mek1Δ::KanMX (pSL386, LEU2) 
[mek1Δ/ySL1972 = deletion collection, checked by PCR]
This study
ySL1998 skm1Δ + pCSR2 :CSR2 -TAP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, skm1Δ::KanMX (pSL386, LEU2) 
[skm1Δ/ySL1973 = deletion collection, checked by PCR]
This study
ySL1999 kin3Δ + pCSR2 :CSR2 -TAP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, kin3Δ::KanMX (pSL386, LEU2) 
[kin3Δ/ySL1974 = deletion collection, checked by PCR]
This study
ySL2000 WT YCK + pCSR2 :CSR2 -TAP Mat a his3 leu2 ura3-52 (LRB341) (pSL386, LEU2) This study (LRB341: Panek et al., 
1997)
ySL2001 yck1Δ  yck2ts + pCSR2 :CSR2 -TAP Mat a his3 leu2 ura3-52 yck1-1::ura3 yck2-2ts (LRB362) (pSL386, LEU2) This study (LRB362: Panek et al., 
1997)
ySL2021 bcy1Δ + pCSR2 :CSR2 -TAP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, bcy1Δ::KanMX (pSL386, LEU2) 
[bcy1Δ/ySL2019 = deletion collection, checked by PCR]
This study
ySL2022 mrk1Δ + pCSR2 :CSR2 -TAP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, mrk1Δ::KanMX (pSL386, LEU2) 
[mrk1Δ/ySL2020 = deletion collection, checked by PCR]
This study
ySL2023 Hxt6-VC + pTEF :Csr2 -VN Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, HXT6-VC::KanMX (pSL391, LEU2) This study
ySL2025 vrp1Δ Hxt6-VC + pTEF :Csr2 -VN Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, vrp1Δ::hphNT1 HXT6-VC::KanMX 
(pSL391, LEU2)
This study
ySL2026 Hxt6-VC + pTEF :Csr2(KR) -VN Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, HXT6-VC::KanMX (pSL393, LEU2) This study
ySL2027 Hxt6-VC + pTEF:VN Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, HXT6-VC::KanMX (pSL394, LEU2) This study
ySL2028 vrp1Δ Hxt6-VC + pTEF:VN Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, vrp1Δ::hphNT1 HXT6-VC::KanMX 
(pSL394, LEU2)
This study
ySL2031 ypk1Δ + pCSR2 :CSR2 -TAP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, ypk1Δ::KanMX (pSL386, LEU2) 
[ypk1Δ/ySL2029 = this study]
This study
ySL2032 gcn2Δ + pCSR2 :CSR2 -TAP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, gcn2Δ::KanMX (pSL386, LEU2) 
[gcn2Δ/ySL2030 = this study]
This study
ySL2043 bcy1Δ + pCSR2 :CSR2(S /T -A) -TAP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, bcy1Δ::KanMX (pSL387, LEU2) This study
ySL2067 csr2-1 Hxt5-GFP Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, csr2-1:: hphNT1, HXT5::GFP-HIS3MX This study
ySL2070 bcy1Δ + pCSR2 :CSR2(Δ150) -3HA Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, bcy1Δ::KanMX (pSL325, LEU2) This study
ySL2071 bcy1Δ + pCSR2 :CSR2(Δ150, 
KR)-3HA
Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, bcy1Δ::KanMX (pSL345, LEU2) This study
ySL2085 WT (PKA) + pCSR2 :CSR2 -TAP Mat α gal1::HIS3 ade2-1 can1-100 his3-11, 15 leu2-3, 112 trp1-1 GAL (= 
Y2864) (pSL386, LEU2) trp1-1, GAL; mat α
This study (Y2864: Zaman et al., 
2009)
ySL2086 pkaas + pCSR2 :CSR2 -TAP Mat α ade2-1 can1-100 his3-11, 15 leu2-3, 112 trp1-1 ura3-1 tpk1M164G 
tpk2M147G tpk3M165G (=Y3561) (pSL386, LEU2)
This study (Y3561: Zaman et al., 
2009)
ySL2085 WT (PKA) + pCSR2 :CSR2 -TAP Mat α gal1::HIS3 ade2-1 can1-100 his3-11, 15 leu2-3, 112 trp1-1 GAL (= 
Y2864) (pSL386, LEU2)
This study (Y2864: Zaman et al., 
2009)
ySL2086 pkaas + pCSR2 :CSR2 -TAP Mat α ade2-1 can1-100 his3-11, 15 leu2-3, 112 trp1-1 ura3-1 tpk1M164G 
tpk2M147G tpk3M165G (=Y3561) (pSL386, LEU2)
This study (Y3561: Zaman et al., 
2009)
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Table S3. Plasmids used in this study
Name Description Origin/reference
pSL168 pCSR2 :lacZ, 2µ, URA3 (Yep358-based) This study
pSL206 (Yep352-6xHis-Ub) pCUP1 :6xHis -Ubi, 2µ, URA3 (Yep352-based) Gwizdek et al., 2006
pSL308 pCSR2 :CSR2 -3HA, CEN, LEU2 (pRS415-based) This study
pSL315 Genomic clone YGPM32j02 in pGP564-based vector (genomic tiling collection;  
chr.XVI :625682 -639002)
Jones et al., 2008
pSL316 pCSR2 :CSR2, CEN, URA3 (pRS416-based; −500/+300) This study
pSL318 pCSR2 :CSR2 -KR -3HA, CEN, LEU2 (pRS415-based) This study
pSL319 pCSR2 :CSR2 -PYm -3HA, CEN, LEU2 (pRS415-based) This study
pSL324 pECM21 :ECM21 -3HA, CEN, LEU2 (pRS415-based) This study
pSL325 pCSR2 :CSR2(Δ150) -3HA, CEN, LEU2 (pRS415-based) This study
pSL345 pCSR2 :CSR2(Δ150,KR) -3HA, CEN, LEU2 (pRS415-based) This study
pSL351 pCSR2 :CSR2(S /T -A) -3HA, CEN, LEU2 (pRS415-based) This study
pSL358 Genomic clone YGPM19n08 in pGP564-based vector (genomic tiling collection;  
chr.XVI :618165 -631521)
Jones et al., 2008
pSL386 pCSR2 :CSR2 -TAP, CEN, LEU2 This study
pSL387 pCSR2 :CSR2(S /T -A) -TAP, CEN, LEU2 This study
pSL391 pTEF :CSR2 -VN, CEN, LEU2 (pRS415-based) This study
pSL393 pTEF :CSR2 -KR -VN, CEN, LEU2 (pRS415-based) This study
pSL392 pTEF:VN, CEN, LEU2 (pRS415-based) This study
pSL404 PMSN2 :MSN2 -GFP, CEN, LEU2 (pRS415-based) Durchschlag et al., 2004
pRHT91 pRS315, CEN, LEU2 Sikorski and Hieter, 1989
pRHT95 pRS416, CEN, URA3 Christianson et al., 1992
Table S4. Primers used in this study
Plasmid number Primer sequence (cloning)
pSL168 oSL437: 5′-TCC GGA ATT CTA TGG TGT TCA GGT CTT TCT CG-3′
oSL438: 5′-TCC GGG ATC CCA TGA TTG ACT TTG CTT ACT AGT CTG-3′
pSL316 oSL713: 5′-GCC TCT CGA GAC TTG TCC CAA CCT CAT TCC-3′
oSL714: 5′-GCC TTC TAG ATA GGC CCA TCA TCT AAT GAT-3′
pSL318 oSL715: 5′-CCT CTA GTA AGA TCT CTT AGT GTC AAG AGA ATTC-3′
oSL716: 5′-GAC ACT AAG AGA TCT TAC TAG AGG TGC CAC TTTA-3′
pSL319 oSL448: 5′-ATA CAC AGC GAA CCA GCCC-3′
oSL656: 5′-GCC TGT CGA CTT ATG ATG AAA TCT CGT CAG CTC GAG GTG GTT CAG-3′
oSL662: 5′-TCT ACC ACC AGC TGG TAT CGA TCT TTT CGA CC-3′
oSL663: 5′-ATC GAT ACC AGC TGG TGG TAG ACT TGC AGC TT-3′
pSL324 oSL751: 5′-TCC GCT CGA GTT CTT CAT CAC TCA TCA AAG GCAC-3′
oSL770: 5′-TCC GAC TAG TAA ATT TAT TAT TTC GAC AGTC-3′
pSL325 oSL768: 5′-CCC GTC TAG AAT GGT CGC GGC AAA ACA AAT ATC TAG-3′
oSL440: 5′-GCC TCT CGA GTG ATG AAA TCT CGT CAT ATC TTGG-3′
pSL345 oSL768: see above
oSL440: see above
pSL386 oSL806: 5′-TCC AAT AAT TCA TCC GGG TCC TGA ACC ACC AAG ATA TGA CGA GAT TTC ATC ACG TAC GCT GCA GGT CGAC-3′
oSL807: 5′-GGG GGG AGG GCG TGA ATG TAA GCG TGA CAT AAC TAA TTA CAT GAC TCG ACC TAA AGA GCC GCG GAA TTCG-3′
pSL387 oSL806: see above
oSL807: see above
pSL391 oSL1007: 5′-TTG TTC TAG AAT GCA ATC TAC TGT CCCA-3′
oSL1008: 5′-CGC CTC GAG TTA CTC GAT GTT GTG GCG-3′
pSL392 oSL1046: 5′-TTG TGG ATC CAT GAG ATC CAT CGC CACC-3′
oSL1047: 5′-CGC CTC GAG TTA ACT TAT AAT ACA ACA-3′
Primer sequence (quantitative RT-PCR)
oSL685 5′-CCA GCC CCT CTA ATA CAG CA-3′
oSL686 5′-ACT CGC AAC AAA GGA ATC CG-3′
oSL704 5′-ACG TTA CCC AAT TGA ACA CG-3′
oSL705 5′-AGA ACA GGG TGT TCT TCT GG-3′
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